ONTOLOGY REPORT - ANNOTATIONS
| Term: | diarsenic trioxide |
|
| Accession: | CHEBI:30621
|
browse the term
|
| Definition: | An arsenic oxide that has formula As4O6. |
| Synonyms: | exact_synonym: | tricyclo[3.3.1.1(3,7)]tetraarsoxane |
| | related_synonym: | Acide arsenieux; Anhydride arsenieux; Arsenic blanc; Arsenic trioxide; Arsenigen saure; Arsenous oxide; Arsenous oxide anhydride; As2O3; As4O6; Diarsenic oxide; InChI=1S/As4O6/c5-1-6-3-8-2(5)9-4(7-1)10-3; InChIKey=KTTMEOWBIWLMSE-UHFFFAOYSA-N; O1[As]2O[As]3O[As]1O[As](O2)O3; White arsenic; arsenic(III) oxide |
| | xref_casrn: | 1327-53-3 |
| | xref: | ChemIDplus:1327-53-3 "CAS Registry Number"; DrugBank:DB01169 "DrugBank"; Gmelin:35185 "Gmelin Registry Number"; KEGG DRUG:D02106 "KEGG DRUG" |
| | xref_mesh: | MESH:C006632 |
| | xref: | NIST Chemistry WebBook:1327-53-3 "CAS Registry Number"; Reaxys:16502683 "Reaxys Registry Number"; Wikipedia:Arsenic_trioxide "Wikipedia" |
|
|
diarsenic trioxide
|
| G |
Abca9 |
ATP-binding cassette, subfamily A (ABC1), member 9 |
|
increases expression |
ISO |
10 |
99,558,803 |
99,619,870 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
decreases expression |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
decreases response to substance |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
decreases response to substance |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
decreases expression |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc5 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 5 |
|
increases expression |
ISO |
11 |
82,714,334 |
82,809,354 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
increases expression |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
multiple interactions |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
decreases expression |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
decreases expression |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Ablim1 |
actin-binding LIM protein 1 |
|
increases expression |
ISO |
1 |
263,380,818 |
263,465,905 |
RGD:6480464 |
CTD |
| G |
Ablim1 |
actin-binding LIM protein 1 |
|
decreases response to substance |
ISO |
1 |
263,380,818 |
263,465,905 |
RGD:6480464 |
CTD |
| G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
|
increases expression |
ISO |
18 |
71,587,259 |
71,632,610 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
decreases expression |
ISO |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
increases expression |
ISO |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
decreases expression |
ISO |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
decreases expression |
ISO |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
decreases expression |
ISO |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
increases expression |
ISO |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Actg1 |
actin, gamma 1 |
|
decreases expression |
ISO |
10 |
109,773,489 |
109,776,334 |
RGD:6480464 |
CTD |
| G |
Actl6b |
actin-like 6B |
|
increases expression |
ISO |
12 |
19,621,722 |
19,638,202 |
RGD:6480464 |
CTD |
| G |
Actn3 |
actinin alpha 3 |
|
decreases expression |
ISO |
1 |
207,475,569 |
207,492,267 |
RGD:6480464 |
CTD |
| G |
Acvrl1 |
activin A receptor type II-like 1 |
|
decreases expression |
ISO |
7 |
139,873,596 |
139,884,675 |
RGD:6480464 |
CTD |
| G |
Acy1 |
aminoacylase 1 |
|
decreases expression |
ISO |
8 |
111,576,888 |
111,581,571 |
RGD:6480464 |
CTD |
| G |
Adamdec1 |
ADAM-like, decysin 1 |
|
increases expression |
ISO |
15 |
48,250,970 |
48,272,395 |
RGD:6480464 |
CTD |
| G |
Adamts2 |
ADAM metallopeptidase with thrombospondin type 1 motif, 2 |
|
decreases expression |
ISO |
10 |
36,168,655 |
36,377,640 |
RGD:6480464 |
CTD |
| G |
Adap1 |
ArfGAP with dual PH domains 1 |
|
decreases response to substance |
ISO |
12 |
15,825,017 |
15,877,643 |
RGD:6480464 |
CTD |
| G |
Adar |
adenosine deaminase, RNA-specific |
|
increases expression |
ISO |
2 |
181,935,246 |
181,956,039 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
decreases expression |
ISO |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
multiple interactions |
ISO |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
increases expression |
ISO |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Adra2b |
adrenoceptor alpha 2B |
|
decreases expression |
ISO |
3 |
114,867,357 |
114,869,680 |
RGD:6480464 |
CTD |
| G |
Adss |
adenylosuccinate synthase |
|
decreases expression |
ISO |
13 |
93,681,036 |
93,711,373 |
RGD:6480464 |
CTD |
| G |
Afap1 |
actin filament associated protein 1 |
|
increases expression |
ISO |
14 |
80,355,358 |
80,448,224 |
RGD:6480464 |
CTD |
| G |
Aff4 |
AF4/FMR2 family, member 4 |
|
decreases expression |
ISO |
10 |
38,798,873 |
38,883,154 |
RGD:6480464 |
CTD |
| G |
Aftph |
aftiphilin |
|
increases expression |
ISO |
14 |
101,482,829 |
101,536,786 |
RGD:6480464 |
CTD |
| G |
Aftph |
aftiphilin |
|
decreases response to substance |
ISO |
14 |
101,482,829 |
101,536,786 |
RGD:6480464 |
CTD |
| G |
Agpat2 |
1-acylglycerol-3-phosphate O-acyltransferase 2 |
|
decreases response to substance |
ISO |
3 |
4,769,863 |
4,781,045 |
RGD:6480464 |
CTD |
| G |
Agpat4 |
1-acylglycerol-3-phosphate O-acyltransferase 4 |
|
increases expression |
ISO |
1 |
42,986,809 |
43,096,390 |
RGD:6480464 |
CTD |
| G |
Agr2 |
anterior gradient 2 homolog (Xenopus laevis) |
|
decreases response to substance |
ISO |
6 |
54,695,633 |
54,716,858 |
RGD:6480464 |
CTD |
| G |
Aif1 |
allograft inflammatory factor 1 |
|
decreases expression |
ISO |
20 |
3,714,428 |
3,716,327 |
RGD:6480464 |
CTD |
| G |
Akap12 |
A kinase (PRKA) anchor protein 12 |
|
increases expression |
ISO |
1 |
34,979,039 |
35,068,763 |
RGD:6480464 |
CTD |
| G |
Akap13 |
A kinase (PRKA) anchor protein 13 |
|
increases expression |
ISO |
1 |
131,052,674 |
131,360,512 |
RGD:6480464 |
CTD |
| G |
Akap3 |
A kinase (PRKA) anchor protein 3 |
|
increases expression |
ISO |
4 |
163,241,422 |
163,263,433 |
RGD:6480464 |
CTD |
| G |
Akap9 |
A kinase (PRKA) anchor protein (yotiao) 9 |
|
increases expression |
ISO |
4 |
26,772,929 |
26,803,149 |
RGD:6480464 |
CTD |
| G |
Akr1b1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
|
decreases expression |
ISO |
4 |
61,645,438 |
61,659,530 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Arf1 |
ADP-ribosylation factor 1 |
|
increases expression |
ISO |
10 |
45,516,609 |
45,532,091 |
RGD:6480464 |
CTD |
| G |
Arfip1 |
ADP-ribosylation factor interacting protein 1 |
|
increases expression |
ISO |
2 |
176,275,425 |
176,353,675 |
RGD:6480464 |
CTD |
| G |
Arhgap5 |
Rho GTPase activating protein 5 |
|
increases expression |
ISO |
6 |
72,685,231 |
72,693,052 |
RGD:6480464 |
CTD |
| G |
Arhgdib |
Rho, GDP dissociation inhibitor (GDI) beta |
|
increases expression |
ISO |
4 |
173,967,842 |
173,986,494 |
RGD:6480464 |
CTD |
| G |
Arid1a |
AT rich interactive domain 1A (SWI-like) |
|
increases response to substance |
ISO |
5 |
151,355,617 |
151,398,647 |
RGD:6480464 |
CTD |
| G |
Arid1b |
AT rich interactive domain 1B (Swi1 like) |
|
decreases expression |
ISO |
1 |
40,012,872 |
40,324,266 |
RGD:6480464 |
CTD |
| G |
Arid4b |
AT rich interactive domain 4B (Rbp1 like) |
|
increases response to substance |
ISO |
17 |
59,334,046 |
59,457,079 |
RGD:6480464 |
CTD |
| G |
Arl4c |
ADP-ribosylation factor-like 4C |
|
decreases expression |
ISO |
9 |
87,617,584 |
87,663,028 |
RGD:6480464 |
CTD |
| G |
Arl6ip1 |
ADP-ribosylation factor-like 6 interacting protein 1 |
|
increases expression |
ISO |
1 |
176,332,729 |
176,342,244 |
RGD:6480464 |
CTD |
| G |
Arl6ip5 |
ADP-ribosylation-like factor 6 interacting protein 5 |
|
multiple interactions |
ISO |
4 |
131,929,503 |
131,953,033 |
RGD:6480464 |
CTD |
| G |
Arl6ip5 |
ADP-ribosylation-like factor 6 interacting protein 5 |
|
increases response to substance |
ISO |
4 |
131,929,503 |
131,953,033 |
RGD:6480464 |
CTD |
| G |
Arl6ip5 |
ADP-ribosylation-like factor 6 interacting protein 5 |
|
increases expression |
ISO |
4 |
131,929,503 |
131,953,033 |
RGD:6480464 |
CTD |
| G |
Arl6ip5 |
ADP-ribosylation-like factor 6 interacting protein 5 |
|
multiple interactions |
ISO |
4 |
131,929,503 |
131,953,033 |
RGD:6480464 |
CTD |
| G |
Armc8 |
armadillo repeat containing 8 |
|
increases expression |
ISO |
8 |
104,341,558 |
104,436,086 |
RGD:6480464 |
CTD |
| G |
Armc9 |
armadillo repeat containing 9 |
|
decreases expression |
ISO |
9 |
84,949,896 |
85,040,301 |
RGD:6480464 |
CTD |
| G |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
|
increases expression |
ISO |
1 |
140,535,823 |
140,646,838 |
RGD:6480464 |
CTD |
| G |
Arrdc3 |
arrestin domain containing 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Asah1 |
N-acylsphingosine amidohydrolase (acid ceramidase) 1 |
|
increases expression |
ISO |
16 |
54,279,253 |
54,311,084 |
RGD:6480464 |
CTD |
| G |
Asb5 |
ankyrin repeat and SOCS box-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Asl |
argininosuccinate lyase |
|
increases expression |
ISO |
12 |
27,702,882 |
27,720,230 |
RGD:6480464 |
CTD |
| G |
Asl |
argininosuccinate lyase |
|
decreases response to substance |
ISO |
12 |
27,702,882 |
27,720,230 |
RGD:6480464 |
CTD |
| G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
decreases expression |
ISO |
4 |
32,758,866 |
32,776,220 |
RGD:6480464 |
CTD |
| G |
Asph |
aspartate-beta-hydroxylase |
|
decreases response to substance |
ISO |
5 |
23,495,780 |
23,520,672 |
RGD:6480464 |
CTD |
| G |
Aspm |
asp (abnormal spindle) homolog, microcephaly associated (Drosophila) |
|
increases expression |
ISO |
13 |
52,811,658 |
52,860,925 |
RGD:6480464 |
CTD |
| G |
Ass1 |
argininosuccinate synthase 1 |
|
decreases expression |
ISO |
3 |
10,578,717 |
10,622,332 |
RGD:6480464 |
CTD |
| G |
Asxl2 |
additional sex combs like 2 (Drosophila) |
|
increases expression |
ISO |
6 |
26,400,855 |
26,482,465 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
decreases expression |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf6 |
activating transcription factor 6 |
|
increases expression |
ISO |
13 |
86,543,773 |
86,718,970 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
decreases expression |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
decreases expression |
EXP |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
decreases expression |
ISO |
13 |
80,214,056 |
80,234,576 |
RGD:6480464 |
CTD |
| G |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
decreases response to substance |
ISO |
13 |
80,214,056 |
80,234,576 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
decreases expression |
ISO |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
|
decreases expression |
ISO |
7 |
36,493,661 |
36,600,280 |
RGD:6480464 |
CTD |
| G |
Atp5a1 |
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle |
|
decreases expression |
ISO |
18 |
74,735,267 |
74,743,088 |
RGD:6480464 |
CTD |
| G |
Atp5a1 |
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle |
|
decreases expression |
ISO |
18 |
74,735,267 |
74,743,088 |
RGD:6480464 |
CTD |
| G |
Atp5g1 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9) |
|
decreases expression |
ISO |
10 |
84,788,650 |
84,791,230 |
RGD:6480464 |
CTD |
| G |
Atp5i |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E |
|
increases expression |
ISO |
14 |
1,867,344 |
1,868,472 |
RGD:6480464 |
CTD |
| G |
Atp6v1a |
ATPase, H+ transporting, lysosomal V1 subunit A |
|
increases expression |
ISO |
11 |
58,127,307 |
58,180,225 |
RGD:6480464 |
CTD |
| G |
Atp6v1g1 |
ATPase, H transporting, lysosomal V1 subunit G1 |
|
increases expression |
ISO |
5 |
80,515,635 |
80,521,815 |
RGD:6480464 |
CTD |
| G |
Atp8a1 |
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
|
increases expression |
ISO |
14 |
42,923,309 |
43,165,666 |
RGD:6480464 |
CTD |
| G |
Atpif1 |
ATPase inhibitory factor 1 |
|
increases expression |
ISO |
5 |
152,618,307 |
152,622,024 |
RGD:6480464 |
CTD |
| G |
Atpif1 |
ATPase inhibitory factor 1 |
|
decreases expression |
ISO |
5 |
152,618,307 |
152,622,024 |
RGD:6480464 |
CTD |
| G |
Atr |
ataxia telangiectasia and Rad3 related |
|
increases activity |
ISO |
8 |
100,936,342 |
101,014,881 |
RGD:6480464 |
CTD |
| G |
Bach2 |
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
|
decreases expression |
ISO |
5 |
48,611,805 |
48,881,943 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
affects expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
affects expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases response to substance |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2a1 |
BCL2-related protein A1 |
|
multiple interactions |
ISO |
8 |
94,045,109 |
94,053,777 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
affects response to substance |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l10 |
BCL2-like 10 (apoptosis facilitator) |
|
decreases expression |
EXP |
8 |
80,172,804 |
80,178,851 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases expression |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
multiple interactions |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases expression |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bcl2l14 |
Bcl2-like 14 (apoptosis facilitator) |
|
increases expression |
ISO |
4 |
171,283,106 |
171,325,345 |
RGD:6480464 |
CTD |
| G |
Bcl2l14 |
Bcl2-like 14 (apoptosis facilitator) |
|
decreases response to substance |
ISO |
4 |
171,283,106 |
171,325,345 |
RGD:6480464 |
CTD |
| G |
Bcl2l2 |
Bcl2-like 2 |
|
decreases expression |
EXP |
15 |
32,983,165 |
32,988,018 |
RGD:6480464 |
CTD |
| G |
Bcl3 |
B-cell CLL/lymphoma 3 |
|
multiple interactions |
ISO |
1 |
79,122,801 |
79,137,035 |
RGD:6480464 |
CTD |
| G |
Bcmo1 |
beta-carotene 15,15'-monooxygenase 1 |
|
decreases expression |
ISO |
19 |
47,202,955 |
47,239,225 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
decreases expression |
ISO |
20 |
13,972,773 |
14,097,816 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
decreases expression |
ISO |
20 |
13,972,773 |
14,097,816 |
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
multiple interactions |
ISO |
10 |
90,317,957 |
90,333,329 |
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
increases expression |
ISO |
10 |
90,317,957 |
90,333,329 |
RGD:6480464 |
CTD |
| G |
Bfar |
bifunctional apoptosis regulator |
|
increases expression |
ISO |
10 |
49 |
13,315 |
RGD:6480464 |
CTD |
| G |
Bfar |
bifunctional apoptosis regulator |
|
decreases expression |
EXP |
10 |
49 |
13,315 |
RGD:6480464 |
CTD |
| G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
|
increases expression |
ISO |
4 |
144,139,486 |
144,145,186 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
multiple interactions |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
multiple interactions |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
multiple interactions |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
decreases expression |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
multiple interactions |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
increases cleavage |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
multiple interactions |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
multiple interactions |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Bik |
BCL2-interacting killer (apoptosis-inducing) |
|
increases expression |
EXP |
7 |
121,377,004 |
121,396,609 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
decreases expression |
ISO |
8 |
4,682,202 |
4,696,856 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
affects response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
|
multiple interactions |
ISO |
3 |
105,063,018 |
105,116,145 |
RGD:6480464 |
CTD |
| G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
|
increases phosphorylation |
ISO |
3 |
105,063,018 |
105,116,145 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
8 |
2,038,626 |
2,075,722 |
RGD:6480464 |
CTD |
| G |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
8 |
2,038,626 |
2,075,722 |
RGD:6480464 |
CTD |
| G |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
|
increases expression |
EXP |
8 |
2,038,626 |
2,075,722 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases activity |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases activity |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases cleavage |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases cleavage |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases activity |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases activity |
EXP |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
EXP |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
affects activity |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases cleavage |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases expression |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases cleavage |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
increases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
increases expression |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
decreases expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
increases expression |
ISO |
10 |
13,474,659 |
13,500,979 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
multiple interactions |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccng2 |
cyclin G2 |
|
increases expression |
ISO |
14 |
16,338,132 |
16,346,628 |
RGD:6480464 |
CTD |
| G |
Ccnh |
cyclin H |
|
increases expression |
ISO |
2 |
14,179,894 |
14,200,704 |
RGD:6480464 |
CTD |
| G |
Ccno |
cyclin O |
|
decreases response to substance |
ISO |
2 |
44,377,953 |
44,381,020 |
RGD:6480464 |
CTD |
| G |
Ccpg1 |
cell cycle progression 1 |
|
decreases expression |
ISO |
8 |
77,724,315 |
77,768,060 |
RGD:6480464 |
CTD |
| G |
Cct2 |
chaperonin containing TCP1, subunit 2 (beta) |
|
increases expression |
ISO |
7 |
56,391,341 |
56,404,084 |
RGD:6480464 |
CTD |
| G |
Cct3 |
chaperonin containing Tcp1, subunit 3 (gamma) |
|
increases expression |
ISO |
2 |
180,381,044 |
180,434,152 |
RGD:6480464 |
CTD |
| G |
Cct6a |
chaperonin containing Tcp1, subunit 6A (zeta 1) |
|
increases expression |
ISO |
12 |
27,992,348 |
28,002,578 |
RGD:6480464 |
CTD |
| G |
Cct8 |
chaperonin containing Tcp1, subunit 8 (theta) |
|
increases expression |
ISO |
11 |
27,233,711 |
27,245,369 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
increases expression |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd164 |
CD164 molecule, sialomucin |
|
decreases expression |
ISO |
20 |
45,486,590 |
45,498,166 |
RGD:6480464 |
CTD |
| G |
Cd177 |
CD177 molecule |
|
increases expression |
ISO |
1 |
80,033,098 |
80,053,738 |
RGD:6480464 |
CTD |
| G |
Cd1d1 |
CD1d1 molecule |
|
decreases expression |
ISO |
2 |
179,011,165 |
179,014,672 |
RGD:6480464 |
CTD |
| G |
Cd22 |
CD22 molecule |
|
increases expression |
ISO |
1 |
85,923,707 |
85,938,567 |
RGD:6480464 |
CTD |
| G |
Cd27 |
CD27 molecule |
|
increases expression |
ISO |
4 |
161,351,797 |
161,356,688 |
RGD:6480464 |
CTD |
| G |
Cd34 |
CD34 molecule |
|
multiple interactions |
ISO |
13 |
110,877,594 |
110,896,722 |
RGD:6480464 |
CTD |
| G |
Cd38 |
CD38 molecule |
|
increases response to substance |
ISO |
14 |
72,320,479 |
72,360,329 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
decreases expression |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
decreases expression |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd70 |
Cd70 molecule |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cd70 |
Cd70 molecule |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cd70 |
Cd70 molecule |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cd74 |
Cd74 molecule, major histocompatibility complex, class II invariant chain |
|
increases expression |
ISO |
18 |
56,756,511 |
56,765,711 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
decreases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
increases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cd9 |
CD9 molecule |
|
decreases response to substance |
ISO |
4 |
162,279,462 |
162,312,889 |
RGD:6480464 |
CTD |
| G |
Cd97 |
CD97 molecule |
|
decreases expression |
ISO |
19 |
26,089,268 |
26,108,997 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
increases expression |
ISO |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc23 |
cell division cycle 23 |
|
increases expression |
ISO |
18 |
27,108,516 |
27,128,285 |
RGD:6480464 |
CTD |
| G |
Cdc25a |
cell division cycle 25A |
|
increases expression |
ISO |
8 |
114,237,704 |
114,255,971 |
RGD:6480464 |
CTD |
| G |
Cdc34 |
cell division cycle 34 |
|
decreases expression |
ISO |
7 |
11,534,543 |
11,539,941 |
RGD:6480464 |
CTD |
| G |
Cdc34 |
cell division cycle 34 |
|
increases expression |
ISO |
7 |
11,534,543 |
11,539,941 |
RGD:6480464 |
CTD |
| G |
Cdc37 |
cell division cycle 37 |
|
increases expression |
ISO |
8 |
20,164,150 |
20,176,763 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
increases expression |
ISO |
5 |
156,106,123 |
156,143,040 |
RGD:6480464 |
CTD |
| G |
Cdc42bpa |
CDC42 binding protein kinase alpha |
|
increases expression |
ISO |
13 |
95,640,342 |
95,865,501 |
RGD:6480464 |
CTD |
| G |
Cdc45 |
cell division cycle 45 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
multiple interactions |
ISO |
10 |
87,684,493 |
87,697,865 |
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
increases expression |
ISO |
10 |
87,684,493 |
87,697,865 |
RGD:6480464 |
CTD |
| G |
Cdc7 |
cell division cycle 7 |
|
increases expression |
ISO |
14 |
3,421,621 |
3,441,738 |
RGD:6480464 |
CTD |
| G |
Cdc73 |
cell division cycle 73 |
|
increases expression |
ISO |
13 |
57,441,674 |
57,534,385 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh23 |
cadherin-related 23 |
|
increases expression |
ISO |
20 |
27,622,049 |
28,016,145 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases expression |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
decreases expression |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
affects expression |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases expression |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
decreases methylation |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
multiple interactions |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Chek2 |
checkpoint kinase 2 |
|
multiple interactions |
ISO |
12 |
45,933,900 |
45,965,427 |
RGD:6480464 |
CTD |
| G |
Chit1 |
chitinase 1 (chitotriosidase) |
|
decreases expression |
ISO |
13 |
47,095,240 |
47,109,367 |
RGD:6480464 |
CTD |
| G |
Chka |
choline kinase alpha |
|
increases expression |
ISO |
1 |
206,368,963 |
206,418,526 |
RGD:6480464 |
CTD |
| G |
Chml |
choroideremia-like (Rab escort protein 2) |
|
increases expression |
ISO |
13 |
91,420,770 |
91,422,635 |
RGD:6480464 |
CTD |
| G |
Chmp1a |
charged multivesicular body protein 1A |
|
decreases response to substance |
ISO |
19 |
53,521,981 |
53,530,261 |
RGD:6480464 |
CTD |
| G |
Chrna6 |
cholinergic receptor, nicotinic, alpha 6 (neuronal) |
|
increases expression |
ISO |
16 |
69,012,201 |
69,018,901 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DFFA-like effector a |
|
increases expression |
ISO |
18 |
63,871,538 |
63,896,975 |
RGD:6480464 |
CTD |
| G |
Cideb |
cell death-inducing DFFA-like effector b |
|
decreases expression |
ISO |
15 |
33,916,472 |
33,920,872 |
RGD:6480464 |
CTD |
| G |
Cideb |
cell death-inducing DFFA-like effector b |
|
increases expression |
ISO |
15 |
33,916,472 |
33,920,872 |
RGD:6480464 |
CTD |
| G |
Ciita |
class II, major histocompatibility complex, transactivator |
|
decreases expression |
ISO |
10 |
5,087,174 |
5,133,418 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
decreases expression |
ISO |
1 |
12,721,500 |
12,723,943 |
RGD:6480464 |
CTD |
| G |
Ckap4 |
cytoskeleton-associated protein 4 |
|
decreases expression |
ISO |
7 |
21,360,351 |
21,368,448 |
RGD:6480464 |
CTD |
| G |
Ckm |
creatine kinase, muscle |
|
increases expression |
ISO |
1 |
78,762,202 |
78,772,681 |
RGD:6480464 |
CTD |
| G |
Clcc1 |
chloride channel CLIC-like 1 |
|
decreases expression |
ISO |
2 |
204,245,357 |
204,278,530 |
RGD:6480464 |
CTD |
| G |
Cldn14 |
claudin 14 |
|
decreases expression |
ISO |
11 |
34,142,138 |
34,151,928 |
RGD:6480464 |
CTD |
| G |
Cldn4 |
claudin 4 |
|
decreases response to substance |
ISO |
12 |
22,816,134 |
22,817,932 |
RGD:6480464 |
CTD |
| G |
Cldn7 |
claudin 7 |
|
decreases response to substance |
ISO |
10 |
56,810,947 |
56,813,134 |
RGD:6480464 |
CTD |
| G |
Cldn9 |
claudin 9 |
|
decreases expression |
ISO |
10 |
12,947,423 |
12,948,854 |
RGD:6480464 |
CTD |
| G |
Clec11a |
C-type lectin domain family 11, member A |
|
decreases expression |
ISO |
1 |
94,785,179 |
94,788,320 |
RGD:6480464 |
CTD |
| G |
Clec7a |
C-type lectin domain family 7, member A |
|
decreases expression |
ISO |
4 |
166,723,515 |
166,734,681 |
RGD:6480464 |
CTD |
| G |
Clgn |
calmegin |
|
decreases expression |
ISO |
19 |
26,404,126 |
26,436,081 |
RGD:6480464 |
CTD |
| G |
Clic4 |
chloride intracellular channel 4 |
|
increases expression |
ISO |
5 |
154,005,244 |
154,066,883 |
RGD:6480464 |
CTD |
| G |
Clk1 |
CDC-like kinase 1 |
|
increases expression |
ISO |
9 |
57,070,825 |
57,082,043 |
RGD:6480464 |
CTD |
| G |
Clk3 |
CDC-like kinase 3 |
|
increases expression |
ISO |
8 |
61,519,196 |
61,532,816 |
RGD:6480464 |
CTD |
| G |
Cln3 |
ceroid-lipofuscinosis, neuronal 3 |
|
decreases response to substance |
ISO |
1 |
185,713,096 |
185,724,375 |
RGD:6480464 |
CTD |
| G |
Clta |
clathrin, light chain A |
|
increases expression |
ISO |
5 |
60,484,437 |
60,502,432 |
RGD:6480464 |
CTD |
| G |
Cltb |
clathrin, light chain B |
|
increases expression |
ISO |
17 |
16,063,715 |
16,081,277 |
RGD:6480464 |
CTD |
| G |
Cltc |
clathrin, heavy chain (Hc) |
|
decreases expression |
ISO |
10 |
74,976,825 |
75,032,529 |
RGD:6480464 |
CTD |
| G |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
|
increases expression |
ISO |
8 |
119,149,810 |
119,165,515 |
RGD:6480464 |
CTD |
| G |
Cmtm8 |
CKLF-like MARVEL transmembrane domain containing 8 |
|
decreases expression |
ISO |
8 |
119,209,101 |
119,265,441 |
RGD:6480464 |
CTD |
| G |
Cnbp |
CCHC-type zinc finger, nucleic acid binding protein |
|
decreases expression |
ISO |
4 |
122,033,037 |
122,041,891 |
RGD:6480464 |
CTD |
| G |
Cnnm2 |
cyclin M2 |
|
increases expression |
ISO |
1 |
252,077,259 |
252,195,971 |
RGD:6480464 |
CTD |
| G |
Cnnm4 |
cyclin M4 |
|
decreases response to substance |
ISO |
9 |
35,410,644 |
35,448,730 |
RGD:6480464 |
CTD |
| G |
Cnot2 |
CCR4-NOT transcription complex, subunit 2 |
|
decreases expression |
ISO |
7 |
55,823,982 |
55,880,812 |
RGD:6480464 |
CTD |
| G |
Cnot6l |
CCR4-NOT transcription complex, subunit 6-like |
|
increases expression |
ISO |
14 |
14,924,620 |
15,011,984 |
RGD:6480464 |
CTD |
| G |
Cobll1 |
cordon-bleu WH2 repeat protein-like 1 |
|
increases expression |
ISO |
3 |
47,024,613 |
47,035,010 |
RGD:6480464 |
CTD |
| G |
Cog5 |
component of oligomeric golgi complex 5 |
|
increases expression |
ISO |
6 |
49,523,386 |
50,200,662 |
RGD:6480464 |
CTD |
| G |
Col14a1 |
collagen, type XIV, alpha 1 |
|
increases expression |
ISO |
7 |
91,801,534 |
92,032,966 |
RGD:6480464 |
CTD |
| G |
Col16a1 |
collagen, type XVI, alpha 1 |
|
increases expression |
ISO |
5 |
149,072,905 |
149,126,350 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
decreases expression |
ISO |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
multiple interactions |
ISO |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col6a3 |
collagen, type VI, alpha 3 |
|
decreases expression |
ISO |
9 |
89,990,129 |
90,043,697 |
RGD:6480464 |
CTD |
| G |
Col8a2 |
collagen, type VIII, alpha 2 |
|
decreases expression |
ISO |
5 |
145,679,681 |
145,684,323 |
RGD:6480464 |
CTD |
| G |
Colec10 |
collectin sub-family member 10 (C-type lectin) |
|
decreases expression |
ISO |
7 |
90,784,784 |
90,847,510 |
RGD:6480464 |
CTD |
| G |
Copb1 |
coatomer protein complex, subunit beta 1 |
|
increases expression |
ISO |
1 |
172,199,676 |
172,233,765 |
RGD:6480464 |
CTD |
| G |
Cops5 |
COP9 signalosome subunit 5 |
|
multiple interactions |
ISO |
5 |
8,709,214 |
8,727,277 |
RGD:6480464 |
CTD |
| G |
Coro1a |
coronin, actin binding protein 1A |
|
increases expression |
ISO |
1 |
185,852,741 |
185,857,715 |
RGD:6480464 |
CTD |
| G |
Cox17 |
COX17 cytochrome c oxidase copper chaperone |
|
decreases expression |
ISO |
11 |
64,183,573 |
64,185,985 |
RGD:6480464 |
CTD |
| G |
Cox4i1 |
cytochrome c oxidase subunit IV isoform 1 |
|
increases expression |
ISO |
19 |
51,023,960 |
51,030,200 |
RGD:6480464 |
CTD |
| G |
Cox6a2 |
cytochrome c oxidase subunit VIa polypeptide 2 |
|
decreases expression |
ISO |
1 |
187,464,579 |
187,465,301 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
decreases expression |
ISO |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Cpe |
carboxypeptidase E |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
|
increases expression |
ISO |
1 |
137,556,766 |
137,666,929 |
RGD:6480464 |
CTD |
| G |
Creb5 |
cAMP responsive element binding protein 5 |
|
increases expression |
ISO |
4 |
81,719,509 |
82,033,894 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
multiple interactions |
ISO |
10 |
11,598,680 |
11,724,122 |
RGD:6480464 |
CTD |
| G |
Crem |
cAMP responsive element modulator |
|
increases expression |
ISO |
17 |
62,770,633 |
62,837,670 |
RGD:6480464 |
CTD |
| G |
Crim1 |
cysteine rich transmembrane BMP regulator 1 (chordin like) |
|
increases expression |
ISO |
6 |
962,024 |
1,141,314 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
decreases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Cytl1 |
cytokine like 1 |
|
decreases expression |
ISO |
14 |
78,349,878 |
78,354,888 |
RGD:6480464 |
CTD |
| G |
Darc |
Duffy blood group, chemokine receptor |
|
decreases expression |
ISO |
13 |
89,534,621 |
89,536,179 |
RGD:6480464 |
CTD |
| G |
Dclre1c |
DNA cross-link repair 1C |
|
increases expression |
ISO |
17 |
85,896,581 |
85,928,644 |
RGD:6480464 |
CTD |
| G |
Dcp2 |
decapping mRNA 2 |
|
increases response to substance |
ISO |
18 |
38,050,088 |
38,086,422 |
RGD:6480464 |
CTD |
| G |
Dcx |
doublecortin |
|
increases expression |
ISO |
X |
34,596,262 |
34,672,383 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
multiple interactions |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
affects expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
multiple interactions |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
affects response to substance |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
multiple interactions |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
multiple interactions |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Dffa |
DNA fragmentation factor, alpha subunit |
|
increases expression |
EXP |
5 |
166,179,130 |
166,192,029 |
RGD:6480464 |
CTD |
| G |
Dffa |
DNA fragmentation factor, alpha subunit |
|
increases expression |
ISO |
5 |
166,179,130 |
166,192,029 |
RGD:6480464 |
CTD |
| G |
Dffb |
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) |
|
increases expression |
ISO |
5 |
170,750,718 |
170,762,034 |
RGD:6480464 |
CTD |
| G |
Dgki |
diacylglycerol kinase, iota |
|
increases expression |
ISO |
4 |
64,207,192 |
64,663,627 |
RGD:6480464 |
CTD |
| G |
Diaph1 |
diaphanous-related formin 1 |
|
decreases expression |
ISO |
18 |
30,757,191 |
30,855,548 |
RGD:6480464 |
CTD |
| G |
Diaph3 |
diaphanous homolog 3 (Drosophila) |
|
increases expression |
ISO |
15 |
68,905,784 |
69,267,707 |
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
|
increases expression |
ISO |
1 |
234,392,743 |
234,396,426 |
RGD:6480464 |
CTD |
| G |
Dkk3 |
dickkopf WNT signaling pathway inhibitor 3 |
|
increases expression |
ISO |
1 |
169,924,617 |
169,964,692 |
RGD:6480464 |
CTD |
| G |
Dlk1 |
delta-like 1 homolog (Drosophila) |
|
affects response to substance |
ISO |
6 |
134,022,016 |
134,043,058 |
RGD:6480464 |
CTD |
| G |
Dlx3 |
distal-less homeobox 3 |
|
decreases expression |
ISO |
10 |
83,802,169 |
83,807,565 |
RGD:6480464 |
CTD |
| G |
Dnah7 |
dynein, axonemal, heavy chain 7 |
|
increases expression |
ISO |
9 |
52,217,861 |
52,520,698 |
RGD:6480464 |
CTD |
| G |
Dnaja1 |
DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
increases expression |
ISO |
5 |
58,100,794 |
58,111,705 |
RGD:6480464 |
CTD |
| G |
Dnajb1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
increases expression |
ISO |
19 |
26,213,739 |
26,217,480 |
RGD:6480464 |
CTD |
| G |
Dnajb1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
increases expression |
ISO |
19 |
26,213,739 |
26,217,480 |
RGD:6480464 |
CTD |
| G |
Dnajb1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
multiple interactions |
ISO |
19 |
26,213,739 |
26,217,480 |
RGD:6480464 |
CTD |
| G |
Dnajb2 |
DnaJ (Hsp40) homolog, subfamily B, member 2 |
|
increases expression |
ISO |
9 |
74,517,647 |
74,525,857 |
RGD:6480464 |
CTD |
| G |
Dnajb4 |
DnaJ (Hsp40) homolog, subfamily B, member 4 |
|
increases expression |
ISO |
2 |
250,663,022 |
250,685,242 |
RGD:6480464 |
CTD |
| G |
Dnajb6 |
DnaJ (Hsp40) homolog, subfamily B, member 6 |
|
increases expression |
ISO |
4 |
732,491 |
796,237 |
RGD:6480464 |
CTD |
| G |
Dnajc9 |
DnaJ (Hsp40) homolog, subfamily C, member 9 |
|
increases expression |
ISO |
15 |
4,152,480 |
4,156,756 |
RGD:6480464 |
CTD |
| G |
Dnase1l1 |
deoxyribonuclease 1-like 1 |
|
increases expression |
ISO |
X |
160,327,966 |
160,336,447 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
decreases expression |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
decreases expression |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
decreases activity |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA (cytosine-5-)-methyltransferase 3 alpha |
|
decreases expression |
ISO |
6 |
26,802,612 |
26,878,878 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA (cytosine-5-)-methyltransferase 3 alpha |
|
decreases expression |
ISO |
6 |
26,802,612 |
26,878,878 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA (cytosine-5-)-methyltransferase 3 alpha |
|
decreases expression |
ISO |
6 |
26,802,612 |
26,878,878 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA (cytosine-5-)-methyltransferase 3 alpha |
|
decreases activity |
ISO |
6 |
26,802,612 |
26,878,878 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
decreases activity |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
decreases expression |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
decreases expression |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
decreases expression |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dock3 |
dedicator of cyto-kinesis 3 |
|
increases expression |
ISO |
8 |
112,114,186 |
112,469,166 |
RGD:6480464 |
CTD |
| G |
Dok5 |
docking protein 5 |
|
increases expression |
ISO |
3 |
161,654,964 |
161,729,978 |
RGD:6480464 |
CTD |
| G |
Dpysl2 |
dihydropyrimidinase-like 2 |
|
increases expression |
ISO |
15 |
46,346,413 |
46,413,786 |
RGD:6480464 |
CTD |
| G |
Dpysl2 |
dihydropyrimidinase-like 2 |
|
affects expression |
ISO |
15 |
46,346,413 |
46,413,786 |
RGD:6480464 |
CTD |
| G |
Dsc2 |
desmocollin 2 |
|
decreases response to substance |
ISO |
18 |
11,902,185 |
11,933,989 |
RGD:6480464 |
CTD |
| G |
Dsg2 |
desmoglein 2 |
|
decreases response to substance |
ISO |
18 |
12,306,321 |
12,366,719 |
RGD:6480464 |
CTD |
| G |
Dsg4 |
desmoglein 4 |
|
increases expression |
ISO |
18 |
12,173,507 |
12,209,833 |
RGD:6480464 |
CTD |
| G |
Duox2 |
dual oxidase 2 |
|
increases expression |
ISO |
3 |
109,059,360 |
109,077,106 |
RGD:6480464 |
CTD |
| G |
Dusp16 |
dual specificity phosphatase 16 |
|
decreases expression |
ISO |
4 |
171,620,395 |
171,667,593 |
RGD:6480464 |
CTD |
| G |
Dusp2 |
dual specificity phosphatase 2 |
|
decreases expression |
ISO |
3 |
114,838,605 |
114,840,790 |
RGD:6480464 |
CTD |
| G |
Dusp4 |
dual specificity phosphatase 4 |
|
decreases expression |
ISO |
16 |
61,109,626 |
61,119,981 |
RGD:6480464 |
CTD |
| G |
Dusp5 |
dual specificity phosphatase 5 |
|
decreases expression |
ISO |
1 |
259,754,234 |
259,767,645 |
RGD:6480464 |
CTD |
| G |
Dusp7 |
dual specificity phosphatase 7 |
|
decreases expression |
ISO |
8 |
111,510,358 |
111,515,989 |
RGD:6480464 |
CTD |
| G |
Dusp8 |
dual specificity phosphatase 8 |
|
increases expression |
ISO |
1 |
202,215,086 |
202,229,746 |
RGD:6480464 |
CTD |
| G |
Dyrk1a |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A |
|
increases response to substance |
ISO |
11 |
34,879,733 |
34,970,998 |
RGD:6480464 |
CTD |
| G |
E2f4 |
E2F transcription factor 4, p107/p130-binding |
|
increases expression |
ISO |
19 |
35,112,273 |
35,118,888 |
RGD:6480464 |
CTD |
| G |
Epx |
eosinophil peroxidase |
|
increases expression |
ISO |
10 |
76,160,005 |
76,171,089 |
RGD:6480464 |
CTD |
| G |
Ercc2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Etv4 |
ets variant 4 |
|
decreases expression |
ISO |
10 |
90,808,439 |
90,824,019 |
RGD:6480464 |
CTD |
| G |
Evl |
Enah/Vasp-like |
|
decreases expression |
ISO |
6 |
132,952,804 |
133,019,870 |
RGD:6480464 |
CTD |
| G |
Evpl |
envoplakin |
|
decreases response to substance |
ISO |
10 |
106,336,953 |
106,353,217 |
RGD:6480464 |
CTD |
| G |
Exog |
endo/exonuclease (5'-3'), endonuclease G-like |
|
increases expression |
ISO |
8 |
124,410,416 |
124,430,163 |
RGD:6480464 |
CTD |
| G |
Exosc2 |
exosome component 2 |
|
decreases expression |
ISO |
3 |
10,786,985 |
10,797,248 |
RGD:6480464 |
CTD |
| G |
F12 |
coagulation factor XII (Hageman factor) |
|
decreases response to substance |
ISO |
17 |
15,251,611 |
15,259,583 |
RGD:6480464 |
CTD |
| G |
F13a1 |
coagulation factor XIII, A1 polypeptide |
|
increases expression |
ISO |
17 |
34,093,525 |
34,270,498 |
RGD:6480464 |
CTD |
| G |
F2rl1 |
coagulation factor II (thrombin) receptor-like 1 |
|
decreases response to substance |
ISO |
2 |
25,886,177 |
25,899,128 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
decreases expression |
ISO |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
decreases expression |
ISO |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
decreases expression |
ISO |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
F5 |
coagulation factor V (proaccelerin, labile factor) |
|
increases expression |
ISO |
13 |
79,934,956 |
79,997,285 |
RGD:6480464 |
CTD |
| G |
Fa2h |
fatty acid 2-hydroxylase |
|
decreases response to substance |
ISO |
19 |
41,268,120 |
41,319,682 |
RGD:6480464 |
CTD |
| G |
Fa2h |
fatty acid 2-hydroxylase |
|
decreases expression |
ISO |
19 |
41,268,120 |
41,319,682 |
RGD:6480464 |
CTD |
| G |
Fam110b |
family with sequence similarity 110, member B |
|
increases expression |
ISO |
5 |
19,260,484 |
19,262,132 |
RGD:6480464 |
CTD |
| G |
Fam117b |
family with sequence similarity 117, member B |
|
increases expression |
ISO |
9 |
58,476,287 |
58,544,228 |
RGD:6480464 |
CTD |
| G |
Fam19a5 |
family with sequence similarity 19 (chemokine (C-C motif)-like), member A5 |
|
increases expression |
ISO |
7 |
125,835,416 |
126,056,345 |
RGD:6480464 |
CTD |
| G |
Fam212a |
family with sequence similarity 212, member A |
|
decreases expression |
ISO |
8 |
113,253,800 |
113,255,490 |
RGD:6480464 |
CTD |
| G |
Fam46c |
family with sequence similarity 46, member C |
|
decreases expression |
ISO |
2 |
195,462,849 |
195,481,953 |
RGD:6480464 |
CTD |
| G |
Fanca |
Fanconi anemia, complementation group A |
|
increases expression |
ISO |
19 |
53,587,849 |
53,647,780 |
RGD:6480464 |
CTD |
| G |
Fancc |
Fanconi anemia, complementation group C |
|
increases expression |
ISO |
17 |
7,254,528 |
7,341,500 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
multiple interactions |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
increases response to substance |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fbf1 |
Fas (TNFRSF6) binding factor 1 |
|
increases expression |
ISO |
10 |
106,248,236 |
106,275,749 |
RGD:6480464 |
CTD |
| G |
Fbln5 |
fibulin 5 |
|
increases expression |
ISO |
6 |
126,018,541 |
126,098,234 |
RGD:6480464 |
CTD |
| G |
Fbp1 |
fructose-1,6-bisphosphatase 1 |
|
decreases expression |
ISO |
17 |
7,795,717 |
7,818,041 |
RGD:6480464 |
CTD |
| G |
Fbxl4 |
F-box and leucine-rich repeat protein 4 |
|
increases expression |
ISO |
5 |
37,156,876 |
37,230,228 |
RGD:6480464 |
CTD |
| G |
Fbxl7 |
F-box and leucine-rich repeat protein 7 |
|
decreases expression |
ISO |
2 |
78,232,361 |
78,610,165 |
RGD:6480464 |
CTD |
| G |
Fcgr3a |
Fc fragment of IgG, low affinity IIIa, receptor |
|
increases expression |
ISO |
13 |
86,867,641 |
86,877,665 |
RGD:6480464 |
CTD |
| G |
Fermt1 |
fermitin family member 1 |
|
decreases response to substance |
ISO |
3 |
120,699,769 |
120,744,016 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
decreases expression |
ISO |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
multiple interactions |
ISO |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
decreases expression |
ISO |
3 |
113,468,427 |
113,517,538 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
decreases expression |
ISO |
16 |
70,869,974 |
70,910,045 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
decreases phosphorylation |
ISO |
16 |
70,869,974 |
70,910,045 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
increases expression |
ISO |
16 |
70,869,974 |
70,910,045 |
RGD:6480464 |
CTD |
| G |
Fgfr1op2 |
FGFR1 oncogene partner 2 |
|
increases expression |
ISO |
4 |
184,153,022 |
184,173,961 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
decreases expression |
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:6480464 |
CTD |
| G |
Fgl2 |
fibrinogen-like 2 |
|
decreases expression |
ISO |
4 |
9,176,333 |
9,181,976 |
RGD:6480464 |
CTD |
| G |
Fgr |
Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog |
|
increases expression |
ISO |
5 |
152,119,455 |
152,147,057 |
RGD:6480464 |
CTD |
| G |
Fhl1 |
four and a half LIM domains 1 |
|
increases expression |
ISO |
X |
141,315,765 |
141,329,278 |
RGD:6480464 |
CTD |
| G |
Fhod1 |
formin homology 2 domain containing 1 |
|
decreases expression |
ISO |
19 |
35,144,278 |
35,163,130 |
RGD:6480464 |
CTD |
| G |
Filip1 |
filamin A interacting protein 1 |
|
increases expression |
ISO |
8 |
84,873,131 |
84,902,873 |
RGD:6480464 |
CTD |
| G |
Fkbp11 |
FK506 binding protein 11 |
|
increases expression |
ISO |
7 |
137,490,985 |
137,494,418 |
RGD:6480464 |
CTD |
| G |
Flnb |
filamin B, beta |
|
decreases response to substance |
ISO |
15 |
18,949,027 |
19,082,504 |
RGD:6480464 |
CTD |
| G |
Flt1 |
FMS-related tyrosine kinase 1 |
|
increases expression |
ISO |
12 |
7,858,092 |
8,035,966 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fnbp1l |
formin binding protein 1-like |
|
decreases expression |
ISO |
2 |
219,200,341 |
219,250,986 |
RGD:6480464 |
CTD |
| G |
Fnbp4 |
formin binding protein 4 |
|
increases expression |
ISO |
3 |
75,111,004 |
75,141,649 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
affects expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
affects expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fscn1 |
fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
increases expression |
ISO |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
Fubp1 |
far upstream element (FUSE) binding protein 1 |
|
increases response to substance |
ISO |
2 |
250,749,095 |
250,777,521 |
RGD:6480464 |
CTD |
| G |
Fubp1 |
far upstream element (FUSE) binding protein 1 |
|
decreases expression |
ISO |
2 |
250,749,095 |
250,777,521 |
RGD:6480464 |
CTD |
| G |
Garnl3 |
GTPase activating Rap/RanGAP domain-like 3 |
|
increases expression |
ISO |
3 |
11,976,369 |
12,076,318 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
increases expression |
ISO |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases expression |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Glt6d1 |
glycosyltransferase 6 domain containing 1 |
|
increases expression |
ISO |
3 |
3,979,926 |
3,988,404 |
RGD:6480464 |
CTD |
| G |
Gltp |
glycolipid transfer protein |
|
decreases expression |
ISO |
12 |
43,195,541 |
43,215,694 |
RGD:6480464 |
CTD |
| G |
Glud1 |
glutamate dehydrogenase 1 |
|
decreases expression |
ISO |
16 |
9,965,718 |
9,999,254 |
RGD:6480464 |
CTD |
| G |
Gmps |
guanine monphosphate synthetase |
|
decreases expression |
ISO |
2 |
153,804,512 |
153,840,009 |
RGD:6480464 |
CTD |
| G |
Gnal |
guanine nucleotide binding protein, alpha stimulating, olfactory type |
|
increases expression |
ISO |
18 |
63,595,606 |
63,735,803 |
RGD:6480464 |
CTD |
| G |
Golga2 |
golgin A2 |
|
increases expression |
ISO |
3 |
11,412,088 |
11,434,260 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble |
|
decreases expression |
ISO |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble |
|
increases expression |
ISO |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Got2 |
glutamic-oxaloacetic transaminase 2, mitochondrial |
|
increases expression |
ISO |
19 |
9,629,687 |
9,655,336 |
RGD:6480464 |
CTD |
| G |
Gpc4 |
glypican 4 |
|
decreases expression |
ISO |
X |
138,966,579 |
139,077,074 |
RGD:6480464 |
CTD |
| G |
Gper |
G protein-coupled estrogen receptor 1 |
|
decreases expression |
ISO |
12 |
15,718,615 |
15,719,893 |
RGD:6480464 |
CTD |
| G |
Gpm6a |
glycoprotein m6a |
|
increases expression |
ISO |
16 |
39,670,748 |
39,783,384 |
RGD:6480464 |
CTD |
| G |
Gpn3 |
GPN-loop GTPase 3 |
|
decreases expression |
ISO |
12 |
35,384,028 |
35,392,646 |
RGD:6480464 |
CTD |
| G |
Gpr15 |
G protein-coupled receptor 15 |
|
increases expression |
ISO |
11 |
42,709,928 |
42,712,013 |
RGD:6480464 |
CTD |
| G |
Gprc5a |
G protein-coupled receptor, family C, group 5, member A |
|
decreases response to substance |
ISO |
4 |
171,987,364 |
172,006,276 |
RGD:6480464 |
CTD |
| G |
Gprc5d |
G protein-coupled receptor, family C, group 5, member D |
|
decreases expression |
ISO |
4 |
172,027,523 |
172,039,757 |
RGD:6480464 |
CTD |
| G |
Gpsm3 |
G-protein signaling modulator 3 |
|
decreases expression |
ISO |
20 |
4,259,883 |
4,261,744 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
increases expression |
ISO |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
increases expression |
ISO |
7 |
11,162,521 |
11,165,318 |
RGD:6480464 |
CTD |
| G |
Gramd3 |
GRAM domain containing 3 |
|
increases expression |
ISO |
18 |
52,171,662 |
52,271,700 |
RGD:6480464 |
CTD |
| G |
Grasp |
GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein |
|
decreases expression |
ISO |
7 |
139,970,173 |
139,977,939 |
RGD:6480464 |
CTD |
| G |
Grb10 |
growth factor receptor bound protein 10 |
|
increases expression |
ISO |
14 |
92,814,797 |
92,911,442 |
RGD:6480464 |
CTD |
| G |
Grb2 |
growth factor receptor bound protein 2 |
|
increases expression |
ISO |
10 |
105,722,014 |
105,818,649 |
RGD:6480464 |
CTD |
| G |
Grb7 |
growth factor receptor bound protein 7 |
|
decreases response to substance |
ISO |
10 |
87,252,571 |
87,261,619 |
RGD:6480464 |
CTD |
| G |
Grem1 |
gremlin 1 |
|
decreases expression |
ISO |
3 |
99,597,201 |
99,608,935 |
RGD:6480464 |
CTD |
| G |
Grik4 |
glutamate receptor, ionotropic, kainate 4 |
|
increases expression |
ISO |
8 |
45,510,258 |
45,681,279 |
RGD:6480464 |
CTD |
| G |
Grk4 |
G protein-coupled receptor kinase 4 |
|
increases expression |
ISO |
14 |
81,648,003 |
81,722,480 |
RGD:6480464 |
CTD |
| G |
Grp |
gastrin releasing peptide |
|
decreases expression |
ISO |
18 |
62,162,526 |
62,176,328 |
RGD:6480464 |
CTD |
| G |
Gsdma |
gasdermin A |
|
increases expression |
ISO |
10 |
87,439,818 |
87,452,308 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
affects response to substance |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
increases expression |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases response to substance |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
increases expression |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
increases expression |
ISO |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
multiple interactions |
ISO |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
ISO |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
increases expression |
ISO |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
decreases response to substance |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
decreases response to substance |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
decreases expression |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstz1 |
glutathione S-transferase zeta 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gulp1 |
GULP, engulfment adaptor PTB domain containing 1 |
|
decreases response to substance |
ISO |
9 |
43,660,027 |
43,797,357 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
increases phosphorylation |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
multiple interactions |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
Havcr2 |
hepatitis A virus cellular receptor 2 |
|
increases expression |
ISO |
10 |
31,585,703 |
31,610,825 |
RGD:6480464 |
CTD |
| G |
Hbb |
hemoglobin, beta |
|
affects expression |
ISO |
1 |
161,618,782 |
161,620,193 |
RGD:6480464 |
CTD |
| G |
Hbp1 |
HMG-box transcription factor 1 |
|
increases expression |
ISO |
6 |
50,201,281 |
50,227,095 |
RGD:6480464 |
CTD |
| G |
Hcrtr1 |
hypocretin (orexin) receptor 1 |
|
decreases expression |
ISO |
5 |
149,160,739 |
149,170,736 |
RGD:6480464 |
CTD |
| G |
Hcst |
hematopoietic cell signal transducer |
|
decreases expression |
ISO |
1 |
85,369,349 |
85,371,383 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
multiple interactions |
ISO |
5 |
148,672,515 |
148,699,810 |
RGD:6480464 |
CTD |
| G |
Hdhd3 |
haloacid dehalogenase-like hydrolase domain containing 3 |
|
decreases response to substance |
ISO |
5 |
79,494,960 |
79,498,427 |
RGD:6480464 |
CTD |
| G |
Heca |
headcase homolog (Drosophila) |
|
increases expression |
ISO |
1 |
12,933,861 |
12,947,642 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
decreases expression |
ISO |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hist1h2bd |
histone cluster 1, H2bd |
|
decreases expression |
ISO |
17 |
50,429,266 |
50,429,647 |
RGD:6480464 |
CTD |
| G |
Hist3h3 |
histone cluster 3, H3 |
|
increases acetylation |
ISO |
10 |
45,252,993 |
45,253,403 |
RGD:6480464 |
CTD |
| G |
Hist3h3 |
histone cluster 3, H3 |
|
multiple interactions |
ISO |
10 |
45,252,993 |
45,253,403 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
increases expression |
ISO |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
increases expression |
ISO |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
affects response to substance |
ISO |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hsp90ab1 |
heat shock protein 90 alpha (cytosolic), class B member 1 |
|
affects response to substance |
ISO |
9 |
11,033,496 |
11,038,868 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
affects response to substance |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
affects response to substance |
ISO |
20 |
3,955,274 |
3,957,748 |
RGD:6480464 |
CTD |
| G |
Hspa4 |
heat shock protein 4 |
|
increases expression |
ISO |
10 |
38,705,629 |
38,749,058 |
RGD:6480464 |
CTD |
| G |
Hspa4 |
heat shock protein 4 |
|
increases expression |
ISO |
10 |
38,705,629 |
38,749,058 |
RGD:6480464 |
CTD |
| G |
Hspa4 |
heat shock protein 4 |
|
increases expression |
ISO |
10 |
38,705,629 |
38,749,058 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
multiple interactions |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
affects response to substance |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
multiple interactions |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
increases expression |
ISO |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
decreases expression |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
decreases expression |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
increases expression |
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
increases expression |
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Hsph1 |
heat shock 105/110 protein 1 |
|
increases expression |
ISO |
12 |
5,794,645 |
5,811,453 |
RGD:6480464 |
CTD |
| G |
Hsph1 |
heat shock 105/110 protein 1 |
|
increases expression |
ISO |
12 |
5,794,645 |
5,811,453 |
RGD:6480464 |
CTD |
| G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
|
increases expression |
ISO |
1 |
99,563,187 |
99,577,802 |
RGD:6480464 |
CTD |
| G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
|
decreases response to substance |
ISO |
1 |
99,563,187 |
99,577,802 |
RGD:6480464 |
CTD |
| G |
Htatsf1 |
HIV-1 Tat specific factor 1 |
|
increases response to substance |
ISO |
X |
141,697,471 |
141,711,652 |
RGD:6480464 |
CTD |
| G |
Htr1d |
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
|
decreases response to substance |
ISO |
5 |
155,188,669 |
155,189,793 |
RGD:6480464 |
CTD |
| G |
Htra3 |
HtrA serine peptidase 3 |
|
increases expression |
ISO |
14 |
80,702,016 |
80,730,742 |
RGD:6480464 |
CTD |
| G |
Hyal1 |
hyaluronoglucosaminidase 1 |
|
increases expression |
ISO |
8 |
112,824,562 |
112,826,875 |
RGD:6480464 |
CTD |
| G |
Iars |
isoleucyl-tRNA synthetase |
|
decreases expression |
ISO |
17 |
20,895,852 |
20,942,180 |
RGD:6480464 |
CTD |
| G |
Iars |
isoleucyl-tRNA synthetase |
|
increases expression |
ISO |
17 |
20,895,852 |
20,942,180 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
decreases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
increases expression |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
decreases response to substance |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
decreases expression |
ISO |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Id4 |
inhibitor of DNA binding 4 |
|
multiple interactions |
ISO |
17 |
22,525,292 |
22,527,861 |
RGD:6480464 |
CTD |
| G |
Id4 |
inhibitor of DNA binding 4 |
|
multiple interactions |
ISO |
17 |
22,525,292 |
22,527,861 |
RGD:6480464 |
CTD |
| G |
Ids |
iduronate 2-sulfatase |
|
increases expression |
ISO |
X |
156,641,266 |
156,661,031 |
RGD:6480464 |
CTD |
| G |
Ier2 |
immediate early response 2 |
|
affects expression |
ISO |
19 |
25,159,276 |
25,160,800 |
RGD:6480464 |
CTD |
| G |
Ier5l |
immediate early response 5-like |
|
decreases expression |
ISO |
3 |
9,515,947 |
9,517,538 |
RGD:6480464 |
CTD |
| G |
Ifih1 |
interferon induced with helicase C domain 1 |
|
decreases expression |
ISO |
3 |
44,547,092 |
44,593,969 |
RGD:6480464 |
CTD |
| G |
Ifitm3 |
interferon induced transmembrane protein 3 |
|
increases expression |
ISO |
1 |
201,198,659 |
201,199,768 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
affects expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases activity |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
decreases expression |
ISO |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
ISO |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
decreases expression |
ISO |
9 |
71,966,877 |
71,994,211 |
RGD:6480464 |
CTD |
| G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
|
decreases expression |
ISO |
14 |
33,010,198 |
33,070,055 |
RGD:6480464 |
CTD |
| G |
Igsf6 |
immunoglobulin superfamily, member 6 |
|
decreases expression |
ISO |
1 |
179,911,684 |
179,922,158 |
RGD:6480464 |
CTD |
| G |
Ik |
IK cytokine, down-regulator of HLA II |
|
increases expression |
ISO |
18 |
29,444,004 |
29,458,808 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
decreases expression |
ISO |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Ikbkg |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
|
decreases expression |
ISO |
X |
160,386,558 |
160,420,190 |
RGD:6480464 |
CTD |
| G |
Il12rb2 |
interleukin 12 receptor, beta 2 |
|
increases expression |
ISO |
4 |
96,929,755 |
96,995,733 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
decreases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases phosphorylation |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
decreases expression |
ISO |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
decreases expression |
ISO |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Jund |
jun D proto-oncogene |
|
multiple interactions |
ISO |
16 |
19,239,694 |
19,241,529 |
RGD:6480464 |
CTD |
| G |
Jund |
jun D proto-oncogene |
|
increases expression |
ISO |
16 |
19,239,694 |
19,241,529 |
RGD:6480464 |
CTD |
| G |
Kalrn |
kalirin, RhoGEF kinase |
|
increases expression |
ISO |
11 |
68,124,348 |
68,611,336 |
RGD:6480464 |
CTD |
| G |
Kat5 |
K(lysine) acetyltransferase 5 |
|
decreases expression |
ISO |
1 |
208,233,434 |
208,240,738 |
RGD:6480464 |
CTD |
| G |
Kcng1 |
potassium voltage-gated channel, subfamily G, member 1 |
|
increases expression |
ISO |
3 |
159,427,774 |
159,447,234 |
RGD:6480464 |
CTD |
| G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
decreases localization |
ISO |
4 |
6,192,644 |
6,224,285 |
RGD:6480464 |
CTD |
| G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
increases expression |
ISO |
4 |
6,192,644 |
6,224,285 |
RGD:6480464 |
CTD |
| G |
Kcnk12 |
potassium channel, subfamily K, member 12 |
|
increases expression |
ISO |
6 |
11,281,814 |
11,353,795 |
RGD:6480464 |
CTD |
| G |
Kcnma1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
|
increases expression |
ISO |
15 |
575,136 |
950,275 |
RGD:6480464 |
CTD |
| G |
Kctd12 |
potassium channel tetramerisation domain containing 12 |
|
decreases expression |
ISO |
15 |
86,986,827 |
86,987,810 |
RGD:6480464 |
CTD |
| G |
Kctd6 |
potassium channel tetramerisation domain containing 6 |
|
increases expression |
ISO |
15 |
18,680,992 |
18,684,394 |
RGD:6480464 |
CTD |
| G |
Kctd9 |
potassium channel tetramerisation domain containing 9 |
|
increases expression |
ISO |
15 |
47,272,273 |
47,300,689 |
RGD:6480464 |
CTD |
| G |
Kdm2a |
lysine (K)-specific demethylase 2A |
|
increases expression |
ISO |
1 |
206,903,426 |
206,972,100 |
RGD:6480464 |
CTD |
| G |
Kdm3a |
lysine (K)-specific demethylase 3A |
|
increases expression |
ISO |
4 |
104,866,501 |
104,911,355 |
RGD:6480464 |
CTD |
| G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
increases expression |
ISO |
8 |
20,259,178 |
20,266,351 |
RGD:6480464 |
CTD |
| G |
Kif13b |
kinesin family member 13B |
|
increases expression |
ISO |
15 |
44,011,649 |
44,167,269 |
RGD:6480464 |
CTD |
| G |
Kif21b |
kinesin family member 21B |
|
increases expression |
ISO |
13 |
49,162,330 |
49,202,704 |
RGD:6480464 |
CTD |
| G |
Kif3a |
kinesin family member 3a |
|
increases expression |
ISO |
10 |
39,029,351 |
39,062,570 |
RGD:6480464 |
CTD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
decreases expression |
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:6480464 |
CTD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
decreases phosphorylation |
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:6480464 |
CTD |
| G |
Kitlg |
KIT ligand |
|
increases expression |
ISO |
7 |
37,714,157 |
37,795,722 |
RGD:6480464 |
CTD |
| G |
Kitlg |
KIT ligand |
|
decreases expression |
ISO |
7 |
37,714,157 |
37,795,722 |
RGD:6480464 |
CTD |
| G |
Klc3 |
kinesin light chain 3 |
|
increases expression |
ISO |
1 |
78,912,047 |
78,915,767 |
RGD:6480464 |
CTD |
| G |
Klf11 |
Kruppel-like factor 11 |
|
decreases expression |
ISO |
6 |
42,296,221 |
42,307,925 |
RGD:6480464 |
CTD |
| G |
Klf13 |
Kruppel-like factor 13 |
|
decreases expression |
ISO |
1 |
118,368,164 |
118,398,938 |
RGD:6480464 |
CTD |
| G |
Klf3 |
Kruppel-like factor 3 (basic) |
|
increases expression |
ISO |
14 |
46,203,638 |
46,226,077 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
decreases response to substance |
ISO |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Klf5 |
Kruppel-like factor 5 |
|
decreases response to substance |
ISO |
15 |
83,103,177 |
83,118,363 |
RGD:6480464 |
CTD |
| G |
Klf5 |
Kruppel-like factor 5 |
|
increases expression |
ISO |
15 |
83,103,177 |
83,118,363 |
RGD:6480464 |
CTD |
| G |
Klf9 |
Kruppel-like factor 9 |
|
decreases expression |
ISO |
1 |
226,420,949 |
226,446,376 |
RGD:6480464 |
CTD |
| G |
Klhdc1 |
kelch domain containing 1 |
|
increases expression |
ISO |
6 |
91,193,505 |
91,223,627 |
RGD:6480464 |
CTD |
| G |
Klhdc8a |
kelch domain containing 8A |
|
increases expression |
ISO |
13 |
45,187,911 |
45,195,996 |
RGD:6480464 |
CTD |
| G |
Klhdc9 |
kelch domain containing 9 |
|
increases expression |
ISO |
13 |
87,262,999 |
87,266,145 |
RGD:6480464 |
CTD |
| G |
Klhl24 |
kelch-like family member 24 |
|
increases expression |
ISO |
11 |
83,094,560 |
83,126,617 |
RGD:6480464 |
CTD |
| G |
Klrk1 |
killer cell lectin-like receptor subfamily K, member 1 |
|
increases response to substance |
ISO |
4 |
166,914,786 |
166,922,659 |
RGD:6480464 |
CTD |
| G |
Kpna2 |
karyopherin alpha 2 |
|
multiple interactions |
ISO |
10 |
96,342,214 |
96,352,613 |
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt19 |
keratin 19 |
|
decreases response to substance |
ISO |
10 |
89,080,953 |
89,085,670 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
decreases response to substance |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Kynu |
kynureninase |
|
increases expression |
ISO |
3 |
24,046,242 |
24,195,898 |
RGD:6480464 |
CTD |
| G |
Lamc1 |
laminin, gamma 1 |
|
decreases expression |
ISO |
13 |
68,241,453 |
68,369,419 |
RGD:6480464 |
CTD |
| G |
Lamc2 |
laminin, gamma 2 |
|
decreases response to substance |
ISO |
13 |
68,151,074 |
68,211,117 |
RGD:6480464 |
CTD |
| G |
Lamtor5 |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 |
|
increases expression |
ISO |
2 |
202,753,681 |
202,759,037 |
RGD:6480464 |
CTD |
| G |
Lap3 |
leucine aminopeptidase 3 |
|
decreases expression |
ISO |
14 |
70,680,077 |
70,699,061 |
RGD:6480464 |
CTD |
| G |
Laptm5 |
lysosomal protein transmembrane 5 |
|
increases expression |
ISO |
5 |
149,775,904 |
149,797,951 |
RGD:6480464 |
CTD |
| G |
LOC100359600 |
karyopherin alpha 2-like |
|
multiple interactions |
ISO |
6 |
10,523,393 |
10,524,982 |
RGD:6480464 |
CTD |
| G |
Lztfl1 |
leucine zipper transcription factor-like 1 |
|
increases response to substance |
ISO |
8 |
128,474,651 |
128,489,845 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
decreases activity |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases expression |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
affects activity |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
decreases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk11 |
mitogen-activated protein kinase 11 |
|
multiple interactions |
ISO |
7 |
127,444,055 |
127,449,990 |
RGD:6480464 |
CTD |
| G |
Mapk11 |
mitogen-activated protein kinase 11 |
|
increases activity |
ISO |
7 |
127,444,055 |
127,449,990 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
decreases response to substance |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases activity |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases expression |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases expression |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk7 |
mitogen-activated protein kinase 7 |
|
multiple interactions |
ISO |
10 |
47,649,203 |
47,654,316 |
RGD:6480464 |
CTD |
| G |
Mapk7 |
mitogen-activated protein kinase 7 |
|
decreases activity |
ISO |
10 |
47,649,203 |
47,654,316 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases activity |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
decreases response to substance |
ISO |
8 |
91,839,845 |
91,955,917 |
RGD:6480464 |
CTD |
| G |
Mecom |
MDS1 and EVI1 complex locus |
|
decreases expression |
ISO |
2 |
114,814,409 |
114,882,676 |
RGD:6480464 |
CTD |
| G |
Mep1a |
meprin 1 alpha |
|
increases expression |
ISO |
9 |
13,170,762 |
13,201,094 |
RGD:6480464 |
CTD |
| G |
Mertk |
c-mer proto-oncogene tyrosine kinase |
|
decreases expression |
ISO |
3 |
116,308,387 |
116,416,414 |
RGD:6480464 |
CTD |
| G |
Mgat4b |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B |
|
decreases response to substance |
ISO |
10 |
35,775,757 |
35,785,551 |
RGD:6480464 |
CTD |
| G |
Mgp |
matrix Gla protein |
|
increases expression |
ISO |
4 |
173,910,595 |
173,913,917 |
RGD:6480464 |
CTD |
| G |
Micb |
MHC class I polypeptide-related sequence B |
|
increases expression |
ISO |
1 |
78,199,668 |
78,216,687 |
RGD:6480464 |
CTD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
decreases expression |
ISO |
20 |
13,191,986 |
13,192,851 |
RGD:6480464 |
CTD |
| G |
Mki67ip |
Mki67 (FHA domain) interacting nucleolar phosphoprotein |
|
increases expression |
ISO |
13 |
30,944,169 |
30,953,973 |
RGD:6480464 |
CTD |
| G |
Mknk1 |
MAP kinase-interacting serine/threonine kinase 1 |
|
decreases expression |
ISO |
5 |
136,100,236 |
136,141,344 |
RGD:6480464 |
CTD |
| G |
Mknk1 |
MAP kinase-interacting serine/threonine kinase 1 |
|
increases expression |
ISO |
5 |
136,100,236 |
136,141,344 |
RGD:6480464 |
CTD |
| G |
Mknk1 |
MAP kinase-interacting serine/threonine kinase 1 |
|
multiple interactions |
ISO |
5 |
136,100,236 |
136,141,344 |
RGD:6480464 |
CTD |
| G |
Mknk1 |
MAP kinase-interacting serine/threonine kinase 1 |
|
decreases response to substance |
ISO |
5 |
136,100,236 |
136,141,344 |
RGD:6480464 |
CTD |
| G |
Mknk2 |
MAP kinase-interacting serine/threonine kinase 2 |
|
multiple interactions |
ISO |
7 |
10,550,040 |
10,561,100 |
RGD:6480464 |
CTD |
| G |
Mknk2 |
MAP kinase-interacting serine/threonine kinase 2 |
|
decreases response to substance |
ISO |
7 |
10,550,040 |
10,561,100 |
RGD:6480464 |
CTD |
| G |
Mkrn2 |
makorin, ring finger protein, 2 |
|
increases expression |
ISO |
4 |
151,734,327 |
151,752,629 |
RGD:6480464 |
CTD |
| G |
Mllt10 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 |
|
increases expression |
ISO |
17 |
92,246,466 |
92,389,861 |
RGD:6480464 |
CTD |
| G |
Mmd |
monocyte to macrophage differentiation-associated |
|
increases expression |
ISO |
10 |
78,664,115 |
78,692,402 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
decreases expression |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp12 |
matrix metallopeptidase 12 |
|
decreases expression |
ISO |
8 |
4,249,938 |
4,259,675 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
decreases expression |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
decreases expression |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
decreases expression |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp28 |
matrix metallopeptidase 28 |
|
decreases expression |
ISO |
10 |
71,526,718 |
71,547,699 |
RGD:6480464 |
CTD |
| G |
Mmp7 |
matrix metallopeptidase 7 |
|
decreases expression |
ISO |
8 |
4,526,018 |
4,533,730 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mnt |
max binding protein |
|
decreases expression |
ISO |
10 |
62,146,582 |
62,161,832 |
RGD:6480464 |
CTD |
| G |
Mocos |
molybdenum cofactor sulfurase |
|
increases expression |
ISO |
18 |
16,420,503 |
16,466,040 |
RGD:6480464 |
CTD |
| G |
Mpl |
myeloproliferative leukemia virus oncogene |
|
decreases expression |
ISO |
5 |
138,921,281 |
138,931,990 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
decreases expression |
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpp5 |
membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5) |
|
increases expression |
ISO |
6 |
101,414,657 |
101,471,504 |
RGD:6480464 |
CTD |
| G |
Mrc2 |
mannose receptor, C type 2 |
|
decreases expression |
ISO |
10 |
94,689,202 |
94,752,076 |
RGD:6480464 |
CTD |
| G |
Mrp63 |
mitochondrial ribosomal protein 63 |
|
increases expression |
ISO |
15 |
36,866,920 |
36,867,782 |
RGD:6480464 |
CTD |
| G |
mrpl24 |
mitochondrial ribosomal protein L24 |
|
increases expression |
ISO |
2 |
179,995,713 |
180,001,745 |
RGD:6480464 |
CTD |
| G |
Mrpl30 |
mitochondrial ribosomal protein L30 |
|
increases expression |
ISO |
9 |
36,839,342 |
36,850,101 |
RGD:6480464 |
CTD |
| G |
Mrpl42 |
mitochondrial ribosomal protein L42 |
|
decreases expression |
ISO |
7 |
32,683,441 |
32,707,184 |
RGD:6480464 |
CTD |
| G |
Mrpl49 |
mitochondrial ribosomal protein L49 |
|
decreases response to substance |
ISO |
1 |
208,692,089 |
208,694,868 |
RGD:6480464 |
CTD |
| G |
Mrps12 |
mitochondrial ribosomal protein S12 |
|
decreases expression |
ISO |
1 |
83,845,161 |
83,848,056 |
RGD:6480464 |
CTD |
| G |
Ms4a6a |
membrane-spanning 4-domains, subfamily A, member 6A |
|
increases expression |
ISO |
1 |
214,046,885 |
214,057,578 |
RGD:6480464 |
CTD |
| G |
Mt-atp6 |
mitochondrially encoded ATP synthase 6 |
|
decreases expression |
ISO |
MT |
7,919 |
8,599 |
RGD:6480464 |
CTD |
| G |
Mt-atp6 |
mitochondrially encoded ATP synthase 6 |
|
increases expression |
ISO |
MT |
7,919 |
8,599 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mta1 |
metastasis associated 1 |
|
decreases expression |
ISO |
6 |
138,118,468 |
138,143,983 |
RGD:6480464 |
CTD |
| G |
Mtx1 |
Metaxin 1 |
|
decreases expression |
ISO |
2 |
181,379,690 |
181,381,406 |
RGD:6480464 |
CTD |
| G |
Muc3a |
mucin 3A, cell surface associated |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Nceh1 |
neutral cholesterol ester hydrolase 1 |
|
increases expression |
ISO |
2 |
113,069,474 |
113,128,268 |
RGD:6480464 |
CTD |
| G |
Neu3 |
sialidase 3 (membrane sialidase) |
|
increases expression |
ISO |
1 |
157,172,027 |
157,183,064 |
RGD:6480464 |
CTD |
| G |
Nfe2l1 |
nuclear factor, erythroid derived 2,-like 1 |
|
multiple interactions |
ISO |
10 |
85,570,238 |
85,577,636 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
affects localization |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
affects response to substance |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfia |
nuclear factor I/A |
|
increases expression |
ISO |
5 |
118,152,938 |
118,507,056 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
decreases expression |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
decreases expression |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases expression |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 |
|
decreases expression |
ISO |
1 |
251,521,559 |
251,527,815 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases phosphorylation |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases expression |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases expression |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases expression |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbib |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
|
decreases expression |
ISO |
1 |
83,865,440 |
83,873,010 |
RGD:6480464 |
CTD |
| G |
Nfkbib |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
|
increases expression |
ISO |
1 |
83,865,440 |
83,873,010 |
RGD:6480464 |
CTD |
| G |
Nfkbie |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
|
multiple interactions |
ISO |
9 |
11,044,112 |
11,050,948 |
RGD:6480464 |
CTD |
| G |
Nfkbie |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
|
decreases expression |
ISO |
9 |
11,044,112 |
11,050,948 |
RGD:6480464 |
CTD |
| G |
Nfkbie |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
|
multiple interactions |
ISO |
9 |
11,044,112 |
11,050,948 |
RGD:6480464 |
CTD |
| G |
Ngrn |
neugrin, neurite outgrowth associated |
|
increases expression |
ISO |
1 |
136,075,434 |
136,081,313 |
RGD:6480464 |
CTD |
| G |
Nkd2 |
naked cuticle homolog 2 (Drosophila) |
|
increases expression |
ISO |
1 |
30,252,093 |
30,278,933 |
RGD:6480464 |
CTD |
| G |
Nlgn1 |
neuroligin 1 |
|
increases expression |
ISO |
2 |
111,189,470 |
111,948,145 |
RGD:6480464 |
CTD |
| G |
Nlrp12 |
NLR family, pyrin domain containing 12 |
|
multiple interactions |
ISO |
1 |
64,242,875 |
64,271,212 |
RGD:6480464 |
CTD |
| G |
Nlrp12 |
NLR family, pyrin domain containing 12 |
|
increases expression |
ISO |
1 |
64,242,875 |
64,271,212 |
RGD:6480464 |
CTD |
| G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
|
increases expression |
ISO |
10 |
82,591,705 |
82,601,075 |
RGD:6480464 |
CTD |
| G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
|
increases expression |
ISO |
10 |
82,591,705 |
82,601,075 |
RGD:6480464 |
CTD |
| G |
Nmt1 |
N-myristoyltransferase 1 |
|
increases expression |
ISO |
10 |
92,196,640 |
92,230,571 |
RGD:6480464 |
CTD |
| G |
Nmt2 |
N-myristoyltransferase 2 |
|
increases expression |
ISO |
17 |
86,039,838 |
86,080,243 |
RGD:6480464 |
CTD |
| G |
Nol3 |
nucleolar protein 3 (apoptosis repressor with CARD domain) |
|
decreases response to substance |
ISO |
19 |
35,094,345 |
35,096,012 |
RGD:6480464 |
CTD |
| G |
Nol6 |
nucleolar protein 6 (RNA-associated) |
|
increases expression |
ISO |
5 |
58,523,391 |
58,533,113 |
RGD:6480464 |
CTD |
| G |
Nolc1 |
nucleolar and coiled-body phosphoprotein 1 |
|
decreases expression |
ISO |
1 |
251,297,417 |
251,308,127 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
decreases expression |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nova1 |
neuro-oncological ventral antigen 1 |
|
decreases expression |
ISO |
6 |
66,193,472 |
66,320,240 |
RGD:6480464 |
CTD |
| G |
Npas1 |
neuronal PAS domain protein 1 |
|
increases expression |
ISO |
1 |
76,719,188 |
76,738,565 |
RGD:6480464 |
CTD |
| G |
Nphs2 |
nephrosis 2, idiopathic, steroid-resistant |
|
increases expression |
ISO |
13 |
71,296,482 |
71,308,868 |
RGD:6480464 |
CTD |
| G |
Npm1 |
nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
|
increases expression |
ISO |
10 |
18,051,990 |
18,062,714 |
RGD:6480464 |
CTD |
| G |
Nptx2 |
neuronal pentraxin II |
|
increases expression |
ISO |
12 |
10,359,406 |
10,370,315 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
decreases response to substance |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
decreases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo2 |
NAD(P)H dehydrogenase, quinone 2 |
|
increases expression |
ISO |
17 |
37,255,630 |
37,283,753 |
RGD:6480464 |
CTD |
| G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
|
increases expression |
ISO |
1 |
95,027,197 |
95,032,516 |
RGD:6480464 |
CTD |
| G |
Nr2f6 |
nuclear receptor subfamily 2, group F, member 6 |
|
decreases expression |
ISO |
16 |
18,535,181 |
18,542,627 |
RGD:6480464 |
CTD |
| G |
Os9 |
osteosarcoma amplified 9 |
|
decreases expression |
ISO |
7 |
67,046,802 |
67,073,355 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pax5 |
paired box 5 |
|
increases expression |
ISO |
5 |
61,016,708 |
61,131,315 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
decreases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcolce |
procollagen C-endopeptidase enhancer |
|
decreases expression |
ISO |
12 |
19,672,505 |
19,678,821 |
RGD:6480464 |
CTD |
| G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
|
increases expression |
ISO |
2 |
1,923,309 |
1,970,238 |
RGD:6480464 |
CTD |
| G |
Pcsk5 |
proprotein convertase subtilisin/kexin type 5 |
|
increases expression |
ISO |
1 |
220,961,912 |
221,405,907 |
RGD:6480464 |
CTD |
| G |
Pdcd2 |
programmed cell death 2 |
|
increases expression |
ISO |
1 |
54,412,081 |
54,417,571 |
RGD:6480464 |
CTD |
| G |
Pdcd4 |
programmed cell death 4 |
|
increases expression |
ISO |
1 |
260,183,648 |
260,202,032 |
RGD:6480464 |
CTD |
| G |
Pdcd4 |
programmed cell death 4 |
|
increases expression |
ISO |
1 |
260,183,648 |
260,202,032 |
RGD:6480464 |
CTD |
| G |
Pdcd5 |
programmed cell death 5 |
|
increases expression |
ISO |
1 |
88,194,319 |
88,199,647 |
RGD:6480464 |
CTD |
| G |
Pde2a |
phosphodiesterase 2A, cGMP-stimulated |
|
decreases expression |
ISO |
1 |
158,921,607 |
159,013,829 |
RGD:6480464 |
CTD |
| G |
Pde4a |
phosphodiesterase 4A, cAMP-specific |
|
decreases expression |
ISO |
8 |
20,192,677 |
20,241,557 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
decreases expression |
ISO |
5 |
123,158,156 |
123,533,877 |
RGD:6480464 |
CTD |
| G |
Pde4dip |
phosphodiesterase 4D interacting protein |
|
increases expression |
ISO |
2 |
192,534,747 |
192,671,053 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
decreases expression |
ISO |
12 |
16,151,045 |
16,172,412 |
RGD:6480464 |
CTD |
| G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
|
decreases expression |
ISO |
3 |
108,216,414 |
108,240,138 |
RGD:6480464 |
CTD |
| G |
Pdlim5 |
PDZ and LIM domain 5 |
|
decreases expression |
ISO |
2 |
240,177,301 |
240,304,192 |
RGD:6480464 |
CTD |
| G |
Pdlim7 |
PDZ and LIM domain 7 |
|
increases expression |
ISO |
17 |
15,168,835 |
15,183,983 |
RGD:6480464 |
CTD |
| G |
Pdpk1 |
3-phosphoinositide dependent protein kinase-1 |
|
decreases activity |
ISO |
10 |
13,329,708 |
13,394,080 |
RGD:6480464 |
CTD |
| G |
Pdxk |
pyridoxal (pyridoxine, vitamin B6) kinase |
|
decreases response to substance |
ISO |
20 |
10,541,656 |
10,563,199 |
RGD:6480464 |
CTD |
| G |
Pdzd2 |
PDZ domain containing 2 |
|
decreases expression |
ISO |
2 |
61,828,127 |
61,953,671 |
RGD:6480464 |
CTD |
| G |
Pdzd7 |
PDZ domain containing 7 |
|
increases expression |
ISO |
1 |
250,093,286 |
250,111,651 |
RGD:6480464 |
CTD |
| G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
|
increases expression |
ISO |
10 |
96,056,220 |
96,057,232 |
RGD:6480464 |
CTD |
| G |
Per2 |
period circadian clock 2 |
|
decreases expression |
ISO |
9 |
90,645,342 |
90,687,509 |
RGD:6480464 |
CTD |
| G |
Pex3 |
peroxisomal biogenesis factor 3 |
|
increases expression |
ISO |
1 |
8,316,117 |
8,357,955 |
RGD:6480464 |
CTD |
| G |
Pgc |
progastricsin (pepsinogen C) |
|
decreases expression |
ISO |
9 |
8,723,620 |
8,731,837 |
RGD:6480464 |
CTD |
| G |
Pgd |
phosphogluconate dehydrogenase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pgd |
phosphogluconate dehydrogenase |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pgf |
placental growth factor |
|
decreases expression |
ISO |
6 |
109,215,540 |
109,226,122 |
RGD:6480464 |
CTD |
| G |
Pggt1b |
protein geranylgeranyltransferase type I, beta subunit |
|
decreases expression |
ISO |
18 |
40,410,055 |
40,452,883 |
RGD:6480464 |
CTD |
| G |
Pgm1 |
phosphoglucomutase 1 |
|
increases expression |
ISO |
5 |
120,595,650 |
120,655,915 |
RGD:6480464 |
CTD |
| G |
Phf12 |
PHD finger protein 12 |
|
decreases expression |
ISO |
10 |
64,024,531 |
64,074,458 |
RGD:6480464 |
CTD |
| G |
Phf21a |
PHD finger protein 21A |
|
increases expression |
ISO |
3 |
76,583,850 |
76,759,238 |
RGD:6480464 |
CTD |
| G |
Phkg2 |
phosphorylase kinase, gamma 2 (testis) |
|
increases expression |
ISO |
1 |
186,858,077 |
186,870,601 |
RGD:6480464 |
CTD |
| G |
Phlda1 |
pleckstrin homology-like domain, family A, member 1 |
|
decreases expression |
ISO |
7 |
50,541,011 |
50,543,215 |
RGD:6480464 |
CTD |
| G |
Phlda2 |
pleckstrin homology-like domain, family A, member 2 |
|
decreases expression |
ISO |
1 |
203,878,093 |
203,879,038 |
RGD:6480464 |
CTD |
| G |
Phldb2 |
pleckstrin homology-like domain, family B, member 2 |
|
increases expression |
ISO |
11 |
56,484,223 |
56,564,459 |
RGD:6480464 |
CTD |
| G |
Pi4ka |
phosphatidylinositol 4-kinase, catalytic, alpha |
|
decreases expression |
ISO |
11 |
85,610,281 |
85,726,603 |
RGD:6480464 |
CTD |
| G |
Pigo |
phosphatidylinositol glycan anchor biosynthesis, class O |
|
increases expression |
ISO |
5 |
59,507,316 |
59,515,305 |
RGD:6480464 |
CTD |
| G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
decreases expression |
ISO |
2 |
118,640,277 |
118,672,440 |
RGD:6480464 |
CTD |
| G |
Pik3r2 |
phosphoinositide-3-kinase, regulatory subunit 2 (beta) |
|
decreases expression |
ISO |
16 |
19,171,101 |
19,179,650 |
RGD:6480464 |
CTD |
| G |
Pim1 |
pim-1 oncogene |
|
increases expression |
ISO |
20 |
7,817,403 |
7,821,800 |
RGD:6480464 |
CTD |
| G |
Pir |
pirin (iron-binding nuclear protein) |
|
increases expression |
ISO |
X |
50,864,981 |
50,974,861 |
RGD:6480464 |
CTD |
| G |
Pir |
pirin (iron-binding nuclear protein) |
|
increases expression |
ISO |
X |
50,864,981 |
50,974,861 |
RGD:6480464 |
CTD |
| G |
Pkd2l1 |
polycystic kidney disease 2-like 1 |
|
decreases expression |
ISO |
1 |
249,047,374 |
249,084,997 |
RGD:6480464 |
CTD |
| G |
Pkib |
protein kinase (cAMP-dependent, catalytic) inhibitor beta |
|
decreases expression |
ISO |
20 |
36,655,506 |
36,750,474 |
RGD:6480464 |
CTD |
| G |
Pkmyt1 |
protein kinase, membrane associated tyrosine/threonine 1 |
|
increases expression |
ISO |
10 |
12,982,319 |
12,993,706 |
RGD:6480464 |
CTD |
| G |
Pkmyt1 |
protein kinase, membrane associated tyrosine/threonine 1 |
|
decreases expression |
ISO |
10 |
12,982,319 |
12,993,706 |
RGD:6480464 |
CTD |
| G |
Pknox1 |
PBX/knotted 1 homeobox 1 |
|
decreases expression |
ISO |
20 |
10,019,509 |
10,041,680 |
RGD:6480464 |
CTD |
| G |
Pkp3 |
plakophilin 3 |
|
decreases response to substance |
ISO |
1 |
201,276,790 |
201,287,799 |
RGD:6480464 |
CTD |
| G |
Pla2g1b |
phospholipase A2, group IB, pancreas |
|
increases expression |
ISO |
12 |
42,405,475 |
42,415,189 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
decreases expression |
ISO |
16 |
73,711,323 |
73,736,328 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
increases expression |
ISO |
15 |
3,680,072 |
3,686,232 |
RGD:6480464 |
CTD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
decreases expression |
ISO |
1 |
79,708,646 |
79,712,881 |
RGD:6480464 |
CTD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
decreases expression |
ISO |
1 |
79,708,646 |
79,712,881 |
RGD:6480464 |
CTD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
decreases expression |
ISO |
1 |
79,708,646 |
79,712,881 |
RGD:6480464 |
CTD |
| G |
Plcxd1 |
phosphatidylinositol-specific phospholipase C, X domain containing 1 |
|
decreases expression |
ISO |
12 |
46,726,350 |
46,729,517 |
RGD:6480464 |
CTD |
| G |
Plek2 |
pleckstrin 2 |
|
decreases response to substance |
ISO |
6 |
101,523,558 |
101,541,773 |
RGD:6480464 |
CTD |
| G |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
|
decreases response to substance |
ISO |
13 |
46,078,783 |
46,214,550 |
RGD:6480464 |
CTD |
| G |
Plekhg1 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 1 |
|
decreases expression |
ISO |
1 |
34,591,855 |
34,677,812 |
RGD:6480464 |
CTD |
| G |
Plekhg3 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
|
decreases response to substance |
ISO |
6 |
99,157,196 |
99,175,135 |
RGD:6480464 |
CTD |
| G |
Plekhg6 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 6 |
|
decreases response to substance |
ISO |
4 |
162,185,519 |
162,201,845 |
RGD:6480464 |
CTD |
| G |
Pml |
promyelocytic leukemia |
|
affects localization |
ISO |
8 |
62,020,438 |
62,051,927 |
RGD:6480464 |
CTD |
| G |
Pml |
promyelocytic leukemia |
|
affects localization |
ISO |
8 |
62,020,438 |
62,051,927 |
RGD:6480464 |
CTD |
| G |
Pml |
promyelocytic leukemia |
|
increases degradation |
ISO |
8 |
62,020,438 |
62,051,927 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU class 5 homeobox 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
increases expression |
ISO |
5 |
136,975,780 |
136,991,630 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
increases expression |
ISO |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Prdx2 |
peroxiredoxin 2 |
|
decreases expression |
ISO |
19 |
24,836,199 |
24,841,390 |
RGD:6480464 |
CTD |
| G |
Prdx3 |
peroxiredoxin 3 |
|
multiple interactions |
ISO |
1 |
267,468,371 |
267,481,273 |
RGD:6480464 |
CTD |
| G |
Prdx3 |
peroxiredoxin 3 |
|
decreases expression |
ISO |
1 |
267,468,371 |
267,481,273 |
RGD:6480464 |
CTD |
| G |
Prdx3 |
peroxiredoxin 3 |
|
increases expression |
ISO |
1 |
267,468,371 |
267,481,273 |
RGD:6480464 |
CTD |
| G |
Prdx3 |
peroxiredoxin 3 |
|
affects response to substance |
ISO |
1 |
267,468,371 |
267,481,273 |
RGD:6480464 |
CTD |
| G |
Prdx4 |
peroxiredoxin 4 |
|
increases expression |
ISO |
X |
61,501,206 |
61,516,286 |
RGD:6480464 |
CTD |
| G |
Prelp |
proline/arginine-rich end leucine-rich repeat protein |
|
decreases expression |
ISO |
13 |
46,863,392 |
46,874,172 |
RGD:6480464 |
CTD |
| G |
Prg3 |
proteoglycan 3 |
|
increases expression |
ISO |
3 |
68,219,693 |
68,225,298 |
RGD:6480464 |
CTD |
| G |
Prkar1b |
protein kinase, cAMP dependent regulatory, type I, beta |
|
decreases expression |
ISO |
12 |
16,025,867 |
16,131,129 |
RGD:6480464 |
CTD |
| G |
Prkcb |
protein kinase C, beta |
|
decreases expression |
ISO |
1 |
181,117,512 |
181,459,856 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
multiple interactions |
ISO |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkch |
protein kinase C, eta |
|
increases expression |
ISO |
6 |
96,069,354 |
96,281,790 |
RGD:6480464 |
CTD |
| G |
Prkd3 |
protein kinase D3 |
|
increases expression |
ISO |
6 |
1,727,315 |
1,796,290 |
RGD:6480464 |
CTD |
| G |
Prmt1 |
protein arginine methyltransferase 1 |
|
decreases expression |
ISO |
1 |
95,449,061 |
95,458,267 |
RGD:6480464 |
CTD |
| G |
Prps1 |
phosphoribosyl pyrophosphate synthetase 1 |
|
increases expression |
ISO |
X |
128,249,843 |
128,271,893 |
RGD:6480464 |
CTD |
| G |
Prr16 |
proline rich 16 |
|
increases expression |
ISO |
18 |
46,322,191 |
46,534,140 |
RGD:6480464 |
CTD |
| G |
Prr3 |
proline rich 3 |
|
increases response to substance |
ISO |
20 |
2,941,531 |
2,946,286 |
RGD:6480464 |
CTD |
| G |
Prrc2c |
proline-rich coiled-coil 2C |
|
increases response to substance |
ISO |
13 |
78,332,572 |
78,400,635 |
RGD:6480464 |
CTD |
| G |
Prrg1 |
proline rich Gla (G-carboxyglutamic acid) 1 |
|
increases expression |
ISO |
X |
64,203,026 |
64,316,641 |
RGD:6480464 |
CTD |
| G |
Prss1 |
protease, serine, 1 (trypsin 1) |
|
increases expression |
ISO |
4 |
69,185,877 |
69,189,080 |
RGD:6480464 |
CTD |
| G |
Psat1 |
phosphoserine aminotransferase 1 |
|
decreases expression |
ISO |
1 |
219,268,419 |
219,290,273 |
RGD:6480464 |
CTD |
| G |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
|
decreases expression |
ISO |
16 |
23,194,137 |
23,662,010 |
RGD:6480464 |
CTD |
| G |
Psma1 |
proteasome (prosome, macropain) subunit, alpha type 1 |
|
increases expression |
ISO |
1 |
172,237,763 |
172,248,782 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Pttg1 |
pituitary tumor-transforming 1 |
|
increases expression |
ISO |
10 |
28,527,409 |
28,532,831 |
RGD:6480464 |
CTD |
| G |
Pttg1 |
pituitary tumor-transforming 1 |
|
multiple interactions |
ISO |
10 |
28,527,409 |
28,532,831 |
RGD:6480464 |
CTD |
| G |
Rab5al1 |
Rab5a, member RAS oncogene family-like 1 |
|
increases expression |
ISO |
14 |
73,512,120 |
73,515,650 |
RGD:6480464 |
CTD |
| G |
Rad9a |
RAD9 homolog A (S. pombe) |
|
increases expression |
ISO |
1 |
206,778,534 |
206,785,230 |
RGD:6480464 |
CTD |
| G |
Ralgps1 |
Ral GEF with PH domain and SH3 binding motif 1 |
|
increases expression |
ISO |
3 |
12,146,421 |
12,379,365 |
RGD:6480464 |
CTD |
| G |
Ranbp9 |
RAN binding protein 9 |
|
increases expression |
ISO |
17 |
27,035,105 |
27,128,690 |
RGD:6480464 |
CTD |
| G |
Rap2c |
RAP2C, member of RAS oncogene family |
|
increases expression |
ISO |
X |
137,743,296 |
137,756,412 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
increases degradation |
ISO |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
increases degradation |
ISO |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
| G |
Rbbp4 |
retinoblastoma binding protein 4 |
|
decreases expression |
ISO |
5 |
148,472,397 |
148,492,172 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases expression |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases activity |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases activity |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Relb |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Relb |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rere |
arginine-glutamic acid dipeptide (RE) repeats |
|
increases expression |
ISO |
5 |
167,440,122 |
167,777,271 |
RGD:6480464 |
CTD |
| G |
RGD1306148 |
similar to KIAA0368 |
|
increases expression |
ISO |
5 |
76,827,647 |
76,942,881 |
RGD:6480464 |
CTD |
| G |
RGD1311558 |
similar to 4930506M07Rik protein |
|
increases expression |
ISO |
1 |
265,492,017 |
265,597,362 |
RGD:6480464 |
CTD |
| G |
RGD1559971 |
similar to Na+ dependent glucose transporter 1 |
|
increases expression |
ISO |
20 |
44,078,646 |
44,086,235 |
RGD:6480464 |
CTD |
| G |
RGD1561149 |
similar to mKIAA1522 protein |
|
increases expression |
ISO |
5 |
148,379,359 |
148,387,824 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
decreases expression |
ISO |
13 |
57,891,849 |
57,894,452 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
decreases expression |
ISO |
13 |
57,891,849 |
57,894,452 |
RGD:6480464 |
CTD |
| G |
Rora |
RAR-related orphan receptor A |
|
increases expression |
ISO |
8 |
73,052,282 |
73,817,764 |
RGD:6480464 |
CTD |
| G |
Rpl17l1 |
ribosomal protein L17-like 1 |
|
decreases expression |
ISO |
1 |
64,205,419 |
64,205,973 |
RGD:6480464 |
CTD |
| G |
Rpl17l1 |
ribosomal protein L17-like 1 |
|
increases expression |
ISO |
1 |
64,205,419 |
64,205,973 |
RGD:6480464 |
CTD |
| G |
RT1-CE7 |
RT1 class I, locus CE7 |
|
decreases expression |
ISO |
20 |
3,410,094 |
3,413,041 |
RGD:6480464 |
CTD |
| G |
RT1-CE7 |
RT1 class I, locus CE7 |
|
increases expression |
ISO |
20 |
3,410,094 |
3,413,041 |
RGD:6480464 |
CTD |
| G |
RT1-CE7 |
RT1 class I, locus CE7 |
|
decreases expression |
ISO |
20 |
3,410,094 |
3,413,041 |
RGD:6480464 |
CTD |
| G |
RT1-Da |
RT1 class II, locus Da |
|
decreases expression |
ISO |
20 |
4,636,310 |
4,641,282 |
RGD:6480464 |
CTD |
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
decreases expression |
ISO |
20 |
1,412,553 |
1,416,692 |
RGD:6480464 |
CTD |
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
decreases expression |
ISO |
20 |
1,412,553 |
1,416,692 |
RGD:6480464 |
CTD |
| G |
Sdc2 |
syndecan 2 |
|
decreases expression |
ISO |
7 |
68,290,558 |
68,405,183 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
increases expression |
ISO |
9 |
44,977,430 |
44,995,358 |
RGD:6480464 |
CTD |
| G |
Slc48a1 |
solute carrier family 48 (heme transporter), member 1 |
|
increases expression |
ISO |
7 |
136,492,421 |
136,500,222 |
RGD:6480464 |
CTD |
| G |
Snrpe |
small nuclear ribonucleoprotein polypeptide E |
|
increases expression |
ISO |
13 |
46,522,340 |
46,528,589 |
RGD:6480464 |
CTD |
| G |
Snrpe |
small nuclear ribonucleoprotein polypeptide E |
|
increases response to substance |
ISO |
13 |
46,522,340 |
46,528,589 |
RGD:6480464 |
CTD |
| G |
Spint2 |
serine peptidase inhibitor, Kunitz type, 2 |
|
increases expression |
ISO |
1 |
84,393,845 |
84,416,299 |
RGD:6480464 |
CTD |
| G |
Stab1 |
stabilin 1 |
|
decreases expression |
ISO |
16 |
6,567,583 |
6,597,972 |
RGD:6480464 |
CTD |
| G |
Stk38l |
serine/threonine kinase 38 like |
|
increases expression |
ISO |
4 |
184,316,579 |
184,392,709 |
RGD:6480464 |
CTD |
| G |
Styxl2 |
serine/threonine/tyrosine interacting protein-like2 |
|
increases expression |
ISO |
7 |
60,137,562 |
60,138,233 |
RGD:6480464 |
CTD |
| G |
Tert |
telomerase reverse transcriptase |
|
decreases expression |
ISO |
1 |
30,445,180 |
30,465,942 |
RGD:6480464 |
CTD |
| G |
Tert |
telomerase reverse transcriptase |
|
decreases expression |
ISO |
1 |
30,445,180 |
30,465,942 |
RGD:6480464 |
CTD |
| G |
Tert |
telomerase reverse transcriptase |
|
decreases expression |
ISO |
1 |
30,445,180 |
30,465,942 |
RGD:6480464 |
CTD |
| G |
Tgoln2 |
trans-golgi network protein 2 |
|
decreases expression |
ISO |
4 |
106,110,153 |
106,117,906 |
RGD:6480464 |
CTD |
| G |
Tigd2 |
tigger transposable element derived 2 |
|
decreases expression |
ISO |
4 |
88,214,431 |
88,215,917 |
RGD:6480464 |
CTD |
| G |
Tldc1 |
TBC/LysM-associated domain containing 1 |
|
increases expression |
ISO |
19 |
49,959,688 |
50,055,661 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
increases expression |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
multiple interactions |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfsf8 |
tumor necrosis factor (ligand) superfamily, member 8 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tpd52 |
tumor protein D52 |
|
increases expression |
ISO |
2 |
94,850,203 |
94,880,802 |
RGD:6480464 |
CTD |
| G |
Tuba1b |
tubulin, alpha 1B |
|
increases expression |
ISO |
7 |
137,706,858 |
137,709,839 |
RGD:6480464 |
CTD |
| G |
Ube2h |
ubiquitin-conjugating enzyme E2H |
|
increases expression |
ISO |
4 |
57,121,159 |
57,216,956 |
RGD:6480464 |
CTD |
| G |
Ugt1a8 |
UDP glycosyltransferase 1 family, polypeptide A8 |
|
decreases expression |
ISO |
9 |
87,017,029 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Umodl |
Uromoduilin-like |
|
decreases response to substance |
ISO |
5 |
152,933,448 |
152,945,287 |
RGD:6480464 |
CTD |
| G |
Uqcr11 |
ubiquinol-cytochrome c reductase, complex III subunit XI |
|
decreases expression |
ISO |
7 |
10,816,422 |
10,821,051 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Wapal |
wings apart-like homolog (Drosophila) |
|
increases expression |
ISO |
16 |
10,337,231 |
10,408,154 |
RGD:6480464 |
CTD |
| G |
Wt1 |
Wilms tumor 1 |
|
decreases expression |
ISO |
3 |
90,529,704 |
90,577,280 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
decreases expression |
ISO |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
decreases expression |
ISO |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
decreases expression |
ISO |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
| G |
Zfp334 |
zinc finger protein 334 |
|
decreases expression |
ISO |
3 |
156,421,244 |
156,430,879 |
RGD:6480464 |
CTD |
Term paths to the root
|